Introduction {#s1}
============

Increasing evidence suggests that exposure to stressful environmental conditions during a critical period in the early development of an organism can result in altered gene expression patterns that are maintained into adulthood. In mammals, this \'cellular memory\' of early life stress has been shown to correlate with behavioral phenotypes that persist into adulthood ([@bib93]; [@bib49]). For example, transcription levels of the *glucocorticoid receptor* (GR) gene in the mouse hippocampus are programmed by the maternal care behaviors of the mother towards her pups during the first postnatal week ([@bib18]; [@bib94]; [@bib92]; [@bib81]; [@bib80]). High maternal care behaviors (such as frequent licking and grooming) lead to high GR expression and low stress responses in the pups as adults, whereas low maternal care results in increased DNA methylation, transcriptional silencing of the GR gene, and high stress responses. Intriguingly, this mechanism of gene regulation appears to be conserved in humans, as childhood adversity correlates with increased transcriptional silencing of the GR gene and mental disorders in adults ([@bib50]; [@bib49]; [@bib41]; [@bib40]). However, the molecular mechanisms establishing and maintaining the tissue-specific changes in gene expression in neurons due to environmental inputs during early development remain to be elucidated.

We have shown that environmental stress early in development can also modulate gene expression and behavior in *Caenorhabditis elegans,* thereby establishing nematodes as a model system for investigating the mechanisms underlying developmental programming of gene expression ([@bib30]; [@bib29]). The *C. elegans* life cycle is regulated by environmental cues during a critical period in the first larval stage. If conditions are favorable (low temperature, high food availability, low pheromone concentrations), worms continue to develop through four larval stages to become reproductive adults (control adults, CON). However, if conditions are unfavorable, worms enter the alternative stress-induced dauer diapause stage ([@bib23]; [@bib22]). The [da]{.ul}uer [f]{.ul}ormation (*daf*) decision is regulated by the differential expression of conserved insulin and TGF-β pathways in sensory neurons in response to environmental conditions (reviewed in [@bib17]). Once conditions improve, dauer animals re-enter the reproductive cycle and continue development to become reproductive adults (postdauer adults, PD). We have shown previously that CON and PD adults retain a cellular memory of their developmental history through changes in gene expression, genome-wide chromatin state, and life history traits ([@bib30]). In addition, these altered adult phenotypes are in part dependent on endogenous small interfering RNA pathways (endo-siRNAs) ([@bib29]).

In recent years, our knowledge of *C. elegans* endo-siRNA pathways and their gene targets has increased substantially. Endo-siRNAs are \~20 to 30 nt in length, antisense to coding transcripts, and are categorized into two major groups based on their biogenesis pathways ([@bib20]; [@bib86]). Primary endo-siRNAs are 26 nt long, have a characteristic 5' monophosphate, and are derived from Dicer processing of double-stranded RNA template (26G-siRNAs) ([@bib86]). In somatic tissue, biogenesis of ERGO-1 class 26G-siRNAs is dependent upon the *[e]{.ul}nhanced [R]{.ul}NA[i]{.ul}* (ERI) complex, which consists of the core proteins RNA-dependent RNA polymerase (RdRP) RRF-3, Dicer-related helicase DRH-3, and Tudor domain-containing protein ERI-5 that associate with Dicer DCR-1 ([@bib15]; [@bib64]; [@bib20]; [@bib83]). Through an unknown mechanism, 26G-siRNAs stimulate the production of secondary endo-siRNAs, which are 22 nt in length, have a 5' triphosphate, and are produced through reverse transcription of mRNA templates by RdRPs (22G-siRNAs) ([@bib78]; [@bib76]; [@bib45]; [@bib87]; [@bib2]; [@bib59]; [@bib73]; [@bib86]; [@bib60]). Downstream effector functions of 22G-siRNAs, such as mRNA degradation or chromatin remodeling, are mediated by their associated *[w]{.ul}orm-specific [A]{.ul}r[go]{.ul}naute* protein (WAGO) in the cytoplasm or nucleus ([@bib96]). Additionally, *Mutator* proteins have been shown to be essential for the biogenesis and siRNA amplification of AGO ERGO-1 class 26G- and WAGO class 22G-siRNAs ([@bib98]; [@bib67]; [@bib66]). Although components of the *Mutator* complex are expressed throughout the worm, their functions and cellular localization are specific to the germline or soma ([@bib67]; [@bib66]). Despite our understanding of endo-siRNA biogenesis, how siRNAs target and regulate endogenous genes, particularly in response to environmental cues, is poorly understood.

In this study, we show that expression of the OSM-9 TRPV channel is differentially regulated based on the developmental trajectory of *C. elegans* and describe the molecular mechanisms that regulate expression of this gene as a function of the animal's developmental history. The *osm-9* gene is down-regulated specifically in the ADL chemosensory neurons of PD adults, resulting in a corresponding altered olfactory behavior that is mediated by ADL in an OSM-9-dependent manner. We identify a *cis*-acting motif bound by the DAF-3 SMAD and ZFP-1 (AF10) proteins that is necessary for the down-regulation of *osm-9* in PD adults and demonstrate that both chromatin remodeling and endo-siRNA pathways are major contributors to *osm-9* regulation. Our results suggest a mechanism of *osm-9* regulation whereby the dauer developmental decision, triggered by environmental stress, results in transcriptional silencing of the *osm-9* locus mediated by the TGF-β, chromatin remodeling, and endogenous RNAi pathways. This work describes an elegant mechanism of how tissue-specific changes in gene expression triggered by transient environmental cues can be maintained via developmental programming.

Results {#s2}
=======

Expression of the *osm-9* TRPV gene is regulated by developmental history {#s2-1}
-------------------------------------------------------------------------

Gene expression analyses identified the *osm-9* TRPV channel gene as a candidate gene whose expression is regulated as a consequence of passage through the dauer stage ([@bib30]). *osm-9* is expressed in a subset of head and tail neurons and is required for chemosensory, osmosensory, and mechanosensory behaviors in adult animals ([@bib10]; [@bib13]; [@bib35]; [@bib85]; [@bib95]; [@bib57]; [@bib70]; [@bib89]). To characterize the differential gene expression of *osm-9* between CON and PD adult animals in further detail, we examined the expression pattern of an integrated *gfp* reporter gene driven by 375 bp of *osm-9* upstream regulatory sequences and 18 bp of the first exon (*osm-9*p::*gfp*) ([Figures 1A](#fig1){ref-type="fig"}, [2A](#fig2){ref-type="fig"}). We examined *gfp* expression in CON and PD adults that spent 24 hr in dauer induced by crowding (see Materials and Methods) ([@bib30]). We observed GFP in the majority of AWA and ADL sensory neurons in CON animals ([Figures 1A,B](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). However, while expression in AWA neurons was unaffected, GFP expression was significantly down-regulated in ADL neurons of PD adults ([Figures 1A,B](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). These results suggest that *osm-9* is regulated at the transcriptional level as a consequence of passage through the dauer stage.10.7554/eLife.11642.003Figure 1.The *osm-9* TRPV channel gene is regulated by developmental history.(**A**) An *osm-9*p::*gfp* transgene is expressed in ADL and AWA neurons in CON adults, but is down-regulated in ADL neurons in PD adults. (**B**) *osm-9*p::*gfp* expression in ADL neurons in CON and PD adults that entered dauer due to crowding (egg plates), exposure to crude pheromone with low population density, or starvation. N ≥ 2 trials; n ≥ 40 animals ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). \*\*p\<0.005, \*\*\*p\<1 x 10^--9^, Student's t-test. GFP in AWA is unaffected ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). (**C**) Quantification of *osm-9* mRNA in ADL neurons of CON and PD using smFISH. The graphs represent individual mean and maximum fluorescence measurements for N = 3 biologically independent trials; n ≥ 87 neurons ([Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}). Medians are indicated. \*\*\*p\<1 x 10^--9^, \*\*p = 0.006 \*p = 0.056, Student's t-test. See [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}. (**D**) Ascr\#3 avoidance behavior of CON and PD adults normalized to M13 buffer. N ≥ 3 trials; n ≥ 60 animals ([Figure 1---source data 3](#SD3-data){ref-type="supplementary-material"}). Data for ADL-expressed *osm-9* rescue strains are averages of two extrachromosomal lines. \* indicates CON significantly different from PD; & CON or PD significantly different from wild-type; \$ CON or PD significantly different from *osm-9(ky10)*; One-way ANOVA with LSD posthoc correction, p\<0.05. All error bars represent S.E.M. OSM-9 mediated behaviors modulated by ASH and AWA neurons are unaffected ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.003](10.7554/eLife.11642.003)10.7554/eLife.11642.004Figure 1---source data 1.Spreadsheet of percentages of animals expressing *osm-9*p::*gfp* in ADL neurons of wild-type strains that experienced overcrowding, high pheromone, or starvation conditions.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.004](10.7554/eLife.11642.004)10.7554/eLife.11642.005Figure 1---source data 2.Spreadsheet containing mean and maximum florescence intensities of *osm-9* smFISH probes in wild-type ADL neurons.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.005](10.7554/eLife.11642.005)10.7554/eLife.11642.006Figure 1---source data 3.Spreadsheet containing ascr\#3 avoidance values for CON and PD in wild-type, *osm-9(ky10)*, and ADL-specific, *osm-9* rescue strains.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.006](10.7554/eLife.11642.006)10.7554/eLife.11642.007Figure 1---figure supplement 1.OSM-9 expression in AWA was unaffected by developmental programming.(**A**) *osm-9*p::*gfp* expression in AWA neurons of CON and PD adults. N \> 3 trials; n \> 60 animals. ([Figure 1---figure supplement 1---source data 1](#SD4-data){ref-type="supplementary-material"}). (**B**) Chemotaxis index of CON and PD adults in wild-type and *osm-9(ky10)* strains in response to diacetyl. Behavioral assays were performed as described previously ([@bib91]). Chemotaxis Index was calculated as \[(\# animals at diacetyl) -- (\# animals at control)\] / total \# animals. N = 3 trials; n \> 300 animals. Error bars represent S.E.M. ([Figure 1---figure supplement 1---source data 2](#SD4-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.007](10.7554/eLife.11642.007)10.7554/eLife.11642.008Figure 1---figure supplement 1---source data 1.Spreadsheet containing percentage of animals expressing *osm-9*p::*gfp* in AWA neurons.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.008](10.7554/eLife.11642.008)10.7554/eLife.11642.009Figure 1---figure supplement 1---source data 2.Spreadsheet containing chemotaxis indices in response to diacetyl for wild-type and *osm-9(ky10)* strains.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.009](10.7554/eLife.11642.009)10.7554/eLife.11642.010Figure 1---figure supplement 2.*osm-9* mRNA levels are down-regulated in PD ADL neurons.(**A**) Representative images analyzed for smFISH experiment. (**B**) Graphs represent the average mean and maximum florescence levels of CON and PD ADL neurons with *osm-9* mRNA smFISH probes in arbitrary brightness units (A.B.U.). (**C**) Graphs representing the average mean and maximum fluorescence levels of worm backgrounds. n ≥ 87 neurons over 3 biologically independent trials. Error bars are standard deviation ([Figure 1---figure supplement 2---source data 1](#SD6-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.010](10.7554/eLife.11642.010)10.7554/eLife.11642.011Figure 1---figure supplement 2---source data 1.Spreadsheet containing mean and maximum florescence intensities for *osm-9* smFISH probes in ADL neurons and worm backgrounds.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.011](10.7554/eLife.11642.011)10.7554/eLife.11642.012Figure 1---figure supplement 3.*gfp* mRNA levels are unaltered between CON and PD ADL neurons.(**A**) Quantification of *gfp* mRNA in ADL neurons of CON and PD using smFISH. ADL neurons were identified by expression of *sre-1*p::*gfp*. The graphs represent individual mean and maximum fluorescence measurements for n ≥ 10 neurons over 3 biologically independent trials. \* p = 0.042, Student's t-test. (**B**) Graphs represent the average mean and maximum florescence levels of CON and PD ADL neurons with *gfp* mRNA smFISH probes in arbitrary brightness units (A.B.U.). (**C**) Graphs representing the average mean and maximum fluorescence levels of worm backgrounds. Error bars are standard deviation ([Figure 1---figure supplement 3---source data 1](#SD7-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.012](10.7554/eLife.11642.012)10.7554/eLife.11642.013Figure 1---figure supplement 3---source data 1.Spreadsheet containing normalized and raw mean and maximum florescence intensities for *gfp* smFISH probes in ADL neurons and worm backgrounds.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.013](10.7554/eLife.11642.013)10.7554/eLife.11642.014Figure 2.The PD motif is necessary for the differential regulation of *osm-9*.(**A**) Schematic of *osm-9* promoter driving *gfp* expression. Dotted lines indicate deleted sequences. Purple, blue, red, and yellow boxes represent 18 bp *osm-9* coding sequence, the conserved motif, DAF-3 binding site, and potential DAF-12 binding site, respectively. (**B**) The PD motif DNA sequences of wild-type and mutated versions. Bold \'G\' indicates where wild-type sequence was mutated to guanine. (**C**) GFP expression in CON and PD ADL neurons of strains carrying deletion and mutated versions of *osm-9*p::*gfp*. Data for each deletion and mutation represents the average of two extrachromosomal lines. \* indicates significantly different from wild-type CON or PD; One-way ANOVA with LSD posthoc correction, p\<0.05. All error bars represent S.E.M ([Figure 2---source data 1](#SD8-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.014](10.7554/eLife.11642.014)10.7554/eLife.11642.015Figure 2---source data 1.Spreadsheet of percentages of animals expressing *gfp* in ADL neurons in strains carrying deletion and mutation versions of *osm-9*p::*gfp*.The conserved sequence formula for the PD motif is also included.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.015](10.7554/eLife.11642.015)

To confirm that the differential expression of *osm-9*p::*gfp* was reflective of the endogenous *osm-9* gene, we quantified *osm-9* mRNA molecules in CON and PD ADL neurons using single molecule florescent in situ hybridization (smFISH) ([@bib68]; [@bib36]). We used a transgenic strain expressing GFP in ADL neurons under a promoter whose expression is unaffected upon dauer passage (*sre-1*p::*gfp*) to identify the correct neuron and to quantify the *gfp* mRNA molecules present as a control ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). For both the *osm-9* and *gfp* smFISH probes, we observed that the fluorescent foci within ADL exhibited unequal sizes and intensities; thus, we were not confident that we could resolve the number of individual mRNA molecules simply by counting the number of smFISH loci. Instead, we quantified the fluorescence intensities of ADL neurons as a measure of the *osm-9* and *gfp* mRNA molecules present. We found that ADL neurons in CON adults exhibited significantly greater mean and maximum fluorescence intensities for the *osm-9* mRNA probes compared to PD adults ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In contrast, fluorescence intensities for the *gfp* mRNA probes exhibited overall similar mean and maximum fluorescence levels for PD compared to CON adults ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). We conclude that the differential regulation of the *osm-9*p::*gfp* transgene is reflective of the regulation of the endogenous *osm-9* gene.

Next, we asked whether passage through the dauer stage was necessary for the observed changes in gene expression, or if exposure to high concentrations of pheromone without dauer entry was sufficient as has been reported for the regulation of chemoreceptor genes in a subset of neurons in *C. elegans* ([@bib65]; [@bib56]). To address this question, we allowed wild-type embryos to hatch on plates containing crude pheromone as previously described ([@bib55]). Animals that bypassed dauer entry and animals that entered the dauer stage were recovered separately and examined for *osm-9*p::*gfp* expression in adults. We found that animals that bypassed dauer entry when exposed to high concentrations of dauer pheromone continued to express GFP in ADL neurons, similar to CON animals in our egg plate preparation ([Figure 1B](#fig1){ref-type="fig"}). However, animals that passed through the dauer stage exhibited the expected decrease in *osm-9*p::*gfp* expression in ADL ([Figure 1B](#fig1){ref-type="fig"}). Similarly, animals that were transiently starved in early development continued to express GFP in ADL if they bypassed the dauer stage, but exhibited decreased GFP expression following passage through dauer ([Figure 1B](#fig1){ref-type="fig"}). These results indicate that the down-regulation of *osm-9*p::*gfp* in adults is dependent on passage through the dauer stage regardless of the environmental trigger inducing dauer entry.

ADL-mediated behavior is altered as a consequence of passage through the dauer stage {#s2-2}
------------------------------------------------------------------------------------

To examine the phenotypic consequences of the differential regulation of *osm-9*, we tested whether an ADL-mediated and OSM-9 dependent behavior is affected upon passage through the dauer stage. Wild-type hermaphrodites avoid high concentrations of the dauer pheromone component ascr\#3; this avoidance behavior requires the OSM-9 and OCR-2 TRPV channels in the ADL neurons ([@bib34]). We hypothesized that if the endogenous *osm-9* gene were down-regulated in ADL neurons of PD animals, these animals would fail to avoid ascr\#3 similar to *osm-9* mutants. To test this hypothesis, we examined the ability of wild-type and *osm-9* mutant CON and PD adults to avoid 100 nM ascr\#3 using drop-test assays ([@bib33]; [@bib34]). We observed that wild-type PD adults exhibited a significantly reduced avoidance response to ascr\#3 compared to CON adults ([Figure 1D](#fig1){ref-type="fig"}). However, these animals retained the ability to avoid glycerol, an OSM-9-dependent behavior mediated by the ASH neurons, and were attracted to the odorant diacetyl, an OSM-9-dependent behavior mediated by the AWA neurons ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}; [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}) ([@bib72]; [@bib10]). These observations are consistent with the observed down-regulation of *osm-9* expression in the ADL neurons.

To verify that the decreased ascr\#3 avoidance phenotype in wild-type PD adults was due to decreased expression of *osm-9* in ADL neurons, we restored *osm-9* expression specifically in ADL neurons of *osm-9* mutants by driving the cDNA under *sre-1* upstream regulatory sequences. Since *sre-1* expression is not detectably altered upon passage through the dauer stage ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), we predicted that both CON and PD adults expressing *sre-1*p::*osm-9 cDNA::gfp* transgene would continue to avoid ascr\#3. However, while the transgene rescued the *osm-9* mutant phenotype in CON animals indicating that the fusion protein is functional, avoidance behavior was again decreased in PD animals ([Figure 1D](#fig1){ref-type="fig"}). We also attempted to rescue the decrease in ascr\#3 avoidance in wild-type PD adults by expressing the same *sre-1*p::*osm-9 cDNA::gfp* transgene in ADL neurons. Again, we observed ascr\#3 avoidance behavior similar to wild-type animals without the transgene ([Figure 1D](#fig1){ref-type="fig"}). Although our results thus far have indicated that *osm-9* is regulated at the transcriptional level in response to developmental history, these results suggest that silencing mechanisms might also target the *osm-9* coding sequences or mRNA, or alternatively, additional genes contributing to the ascr\#3 behavior.

*osm-9* down-regulation requires a *cis*-acting promoter motif {#s2-3}
--------------------------------------------------------------

Since transcriptional down-regulation contributes to the decreased *osm-9*p::*gfp* expression in ADL in PD animals, we analyzed *osm-9* upstream regulatory sequences present in the *osm-9*p::*gfp* transgene to identify regulatory motifs contributing to the altered expression. Using bioinformatics-based analyses of *osm-9* upstream regulatory sequences, we identified a 29 bp motif ([Figure 2A](#fig2){ref-type="fig"}) that is present in the upstream regulatory sequences of 977 (4.9%) genes in the genome. This conserved sequence was slightly enriched (121 genes, 5.6%; Z-test, p=0.056) in the regulatory regions of genes that were differentially expressed between CON and PD adults ([@bib30]). We also identified an additional motif, a predicted DAF-3 SMAD binding site, located 22 bp upstream of the conserved sequence ([Figure 2A](#fig2){ref-type="fig"}) ([@bib82]). We will henceforth refer to this combined regulatory sequence as the PD motif. To test the functional relevance of this motif, we generated a series of *osm-9*p::*gfp* transcriptional fusion constructs lacking portions of the *osm-9* regulatory sequences and examined their expression in ADL neurons of CON and PD adults ([Figure 2A,C](#fig2){ref-type="fig"}). Deletion of the PD motif in the context of the 375 bp *osm-9* regulatory sequences (Deletion 1) resulted in continued expression of *gfp* in ADL in PD adults without affecting expression in CON animals, indicating that this *cis*-regulatory motif is required for the down-regulation of *osm-9* in PD ADL neurons ([Figure 2A,C](#fig2){ref-type="fig"}). Deletion of sequences that did not include the PD motif (Deletion 2) resulted in *gfp* expression changes in PD ADL neurons similar to that observed with the full length *osm-9*p::*gfp* transgene ([Figure 2A,C](#fig2){ref-type="fig"}). Deletion 3, which contained the 18 bp of *osm-9* coding sequence in addition to the 375 bp of upstream regulatory sequence, also exhibited down-regulation of *gfp* expression in ADL neurons of PD adults ([Figure 2A,C](#fig2){ref-type="fig"}). These results indicate that the *cis*-acting PD motif is necessary for the transcriptional regulation of *osm-9* due to developmental programming.

To further characterize the PD motif sequence necessary for differential regulation of *osm-9*, we sequentially replaced a subset of bases within the PD motif with guanines and examined *gfp* expression in ADL neurons of CON and PD adults ([Figure 2B,C](#fig2){ref-type="fig"}). Mutated constructs 3 and 5 exhibited significantly increased GFP in ADL neurons of PD adults compared to wild-type ([Figure 2B,C](#fig2){ref-type="fig"}), indicating that these sequences were required for complete down-regulation of *osm-9* in PD adults. However, we found that mutated constructs 1, 2, 4, 6, and 7 resulted in a significant decrease in *osm-9*p::*gfp* expression in both CON and PD ADL neurons ([Figure 2B,C](#fig2){ref-type="fig"}), indicating that these sequences were required for the positive regulation of *osm-9* expression. Together these results suggest a model that, in the absence of the PD motif, the default state of *osm-9* expression in ADL neurons is transcriptional activation, and that the PD motif contains sequences necessary for the negative regulation of *osm-9* in response to developmental history.

The TGF-β pathway negatively regulates *osm-9* in postdauer animals {#s2-4}
-------------------------------------------------------------------

To further illuminate the mechanisms regulating *osm-9* and ascr\#3 avoidance behavior, we sought to identify factors that interact with the upstream regulatory sequences of *osm-9*. In addition to the potential DAF-3 SMAD binding site, further scrutiny of the *osm-9 cis*-regulatory sequences yielded potential binding sites for the DAF-12 nuclear hormone receptor (NHR), which functions downstream of TGF-β and insulin signaling pathways in the regulation of dauer formation ([Figure 2A](#fig2){ref-type="fig"}). To investigate a potential role of the TGF-β and insulin/IGF dauer formation pathways in the regulation of *osm-9*, we examined *osm-9*p::*gfp* expression in CON and PD adults of strains carrying mutations in genes implicated in dauer formation. First, we found that mutations in *daf-3* SMAD and *daf-5* SNO/SKI significantly increased the *gfp* expression observed in PD ADL neurons compared to wild-type animals ([Figure 3A](#fig3){ref-type="fig"}). DAF-3 binds to DAF-5 ([@bib11]), and may act together as negative regulators at the *osm-9* locus. In contrast, the *daf-7* TGF-β mutant strain exhibits a partial but significant decrease in *osm-9*p::*gfp* expression in ADL neurons of both CON and PD animals compared to wild-type, but expression in PD animals is again down-regulated as compared to CON animals ([Figure 3A](#fig3){ref-type="fig"}). This result suggests that dauer formation, and not reduced TGF-β signaling alone, is required for the down-regulation of *osm-9* in PD ADL neurons. In addition, since DAF-7 TGF-β signaling antagonizes DAF-3/DAF-5 function, this result is also consistent with increased DAF-3/DAF-5 activity in a *daf-7* mutant promoting down-regulation of *osm-9* expression ([@bib88]; [@bib84]; [@bib63]). Together these results suggest that DAF-3 and DAF-5 play a role in the developmental programming of *osm-9* in PD ADL neurons.10.7554/eLife.11642.016Figure 3.The TGF-β pathway regulates *osm-9* expression in response to developmental history.(**A**) Percent ADL neurons expressing *osm-9*p::*gfp* in CON and PD adults in wild-type and strains carrying mutations in TGF-β and insulin signaling pathways. GFP expression for Mutation 2 in *daf-3, daf-5*, and *daf-3; daf-5* mutants is found in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. N ≥ 3 trials; n ≥ 60 animals ([Figure 3---source data 1](#SD9-data){ref-type="supplementary-material"}). \* indicates CON or PD significantly different from wild-type; One-way ANOVA with LSD posthoc correction, p\<0.05. n.d., not determined. (**B**) Log2 normalized enrichment of DAF-3 SMAD binding to the *osm-9* DAF-3 binding site (DBS) in *C. elegans* developmental stages. *daf-8* and *daf-14* are positive and negative controls, respectively. Bar graph represents IP-qPCR data, normalized to DAF-3 binding to actin *act-2* promoter ([@bib62]). N ≥ 2 biologically independent trials ([Figure 3---source data 2](#SD10-data){ref-type="supplementary-material"}). \* indicates enriched over background (*daf-3* CON) or between CON and PD as indicated, p\<0.05, Student's t-test. (**C**) Log2 PD/CON ratio of ascr\#3 avoidance behavior in wild-type and strains carrying mutations in TGF-β pathway genes. Data for controls is found in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}. \* indicates significantly different from wild-type; One-way ANOVA with LSD posthoc correction, p\<0.05 ([Figure 3---source data 3](#SD11-data){ref-type="supplementary-material"}). All error bars represent S.E.M.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.016](10.7554/eLife.11642.016)10.7554/eLife.11642.017Figure 3---source data 1.Spreadsheet containing percentages of animals expressing *osm-9*p::*gfp* in ADL neurons in strains carrying mutations in TGF-β and insulin signaling genes.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.017](10.7554/eLife.11642.017)10.7554/eLife.11642.018Figure 3---source data 2.Spreadsheet containing DAF-3 enrichment values in wild-type CON, PD, larval L3, and dauer animals.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.018](10.7554/eLife.11642.018)10.7554/eLife.11642.019Figure 3---source data 3.Spreadsheet containing PD/CON ascr\#3 avoidance ratios for strains carrying mutations in TGF-β and insulin signaling genes.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.019](10.7554/eLife.11642.019)10.7554/eLife.11642.020Figure 3---figure supplement 1.DAF-3 and DAF-5 may also indirectly regulate *osm-9* transcription.Our *osm-9*p::*gfp* expression and ascr\#3 avoidance behavior results both suggested that DAF-3 SMAD and DAF-5 SNO/SKI are acting as a negative regulators of *osm-9* in PD ADL neurons (see [Figure 3](#fig3){ref-type="fig"}). However, mutation of part of the potential DAF-3 binding site (Mutation 2) resulted in a decrease in *osm-9* expression in CON adults. We observed significantly increased GFP expression in ADL neurons of CON adults carrying the Mutation 2 construct in the *daf-3(mgDf90), daf-5(e1386),* and *daf-3(mgDf90); daf-5(e1386)* mutant strains compared to wild-type. We were unable to obtain PD adults in these mutant strains to examine GFP levels. DAF-3 has been shown to negatively regulate the genes *daf-7, daf-8*, and myosin gene *myo-2* by binding to their upstream regulatory sequences ([@bib82]; [@bib62]). Thus, DAF-3 and DAF-5 may be inhibiting activity of an unknown protein that promotes *osm-9* expression when they cannot bind to the PD motif. n ≥ 20 animals over at least 3 biologically independent trials. *osm-9*p::*gfp* data in wild-type, *daf-3(mgDf90)*, and *daf-5(e1386)* and Mutation 2 reproduced from [Figures 2C](#fig2){ref-type="fig"} and [3A](#fig3){ref-type="fig"} for reference. Data for strains carrying Mutation 2 are averages of values for two independent extrachromosomal lines. \* Significantly different from wild-type, & significantly different from Mutation 2, One-way ANOVA, LSD posthoc correction, p\<0.05. Error bars represent S.E.M. ([Figure 3---figure supplement 1---source data 1](#SD12-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.020](10.7554/eLife.11642.020)10.7554/eLife.11642.021Figure 3---figure supplement 1---source data 1.Spreadsheet containing the percentage of animals expressing Mut2 version of *osm-9*p::*gfp* in *daf-3(mgDf90)* and *daf-5(e1386)* strains.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.021](10.7554/eLife.11642.021)10.7554/eLife.11642.022Figure 3---figure supplement 2.Strains tested for ascr\#3 avoidance exhibited expected behaviors for positive and negative controls.(**A**) Fraction of CON adults from strains in [Figures 3C](#fig3){ref-type="fig"}, [4B,](#fig4){ref-type="fig"} and [5B](#fig5){ref-type="fig"} that exhibit ascr\#3 avoidance behavior. (**B**) Fraction of CON and PD adults from strains in [Figures 1D](#fig1){ref-type="fig"}, [3C](#fig3){ref-type="fig"}, [4B,](#fig4){ref-type="fig"} and [5B](#fig5){ref-type="fig"} that exhibit M13 avoidance behavior (negative control). (**C**) Fraction of CON and PD adults from strains in [Figures 1D](#fig1){ref-type="fig"}, [3C](#fig3){ref-type="fig"}, [4B,](#fig4){ref-type="fig"} and [5B](#fig5){ref-type="fig"} that exhibit 1 M glycerol avoidance behavior (positive control). Data for neuron-specific rescue strains is average values for two independent extrachromosomal lines. Error bars represent S.E.M. ([Figure 3---figure supplement 2---source data 1](#SD13-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.022](10.7554/eLife.11642.022)10.7554/eLife.11642.023Figure 3---figure supplement 2---source data 1.Spreadsheet containing avoidance responses CON and PD adults to M13 and 1 M glycerol.Normalized avoidance responses of CON adults to ascr\#3 are also included.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.023](10.7554/eLife.11642.023)

We next asked whether DAF-3 directly interacts with *osm-9 cis*-regulatory sequences. The potential DAF-3 binding site in the PD motif (GTCTA; overlapping with Mutations 2 and 3, [Figure 2B](#fig2){ref-type="fig"}) differs from the previously identified binding site by a single base (GTCTG) ([@bib82]). To test whether DAF-3 does indeed bind to the *osm-9* PD motif, we performed protein immunoprecipitation of DAF-3 from whole animals using a commercially available antibody (Novus Biologicals, Littleton, CO), followed by quantitative PCR (IP-qPCR) in CON and PD adult, dauer, and larval L2/L3 animals. Our results showed that DAF-3 was enriched at the potential DAF-3 binding site (DBS) in the *osm-9* promoter in PD adults compared to other tested stages ([Figure 3B](#fig3){ref-type="fig"}). We also examined DAF-3 enrichment at the *daf-8* and *daf-14* promoters as positive and negative controls, respectively, since their regulation by DAF-3 has been characterized previously ([@bib62]). Although these results do not address DAF-3 enrichment at the PD motif specifically in ADL neurons, nor the precise binding site of DAF-3 (see [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), they are consistent with our model that DAF-3 negatively regulates *osm-9* in PD ADL neurons through a direct interaction at the PD motif.

We next characterized the role of the TGF-β pathway in modulating ascr\#3 avoidance behavior by testing the ascr\#3 avoidance responses of CON and PD animals in strains carrying mutations in *daf-3* SMAD, *daf-7* TGF-β, and *daf-5* SNO/SKI genes. Based on their role in the regulation of *osm-9* transcription ([Figure 3A](#fig3){ref-type="fig"}), we expected to observe an elimination of the difference between the PD and CON ascr\#3 avoidance behavior in *daf-3* and *daf-5* mutant strains and a reduced effect in *daf-7*. Indeed, we observed that mutations in *daf-3* SMAD and *daf-5* SNO/SKI genes eliminated the difference between CON and PD avoidance response to ascr\#3, consistent with DAF-3 and DAF-5 acting as negative regulators of ascr\#3 avoidance in PD animals ([Figure 3C](#fig3){ref-type="fig"}). In addition, a mutation in the *daf-7* TGF-β gene significantly disrupted the PD/CON ascr\#3 avoidance levels compared to wild-type, through a decrease in CON adult ascr\#3 avoidance ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). While most components of the TGF-β pathway exhibit broad expression patterns, DAF-7 TGF-β is expressed in ASI, ADE, and OLQ neurons, suggesting that a molecular signal from one of these sensory neurons may regulate *osm-9* expression in ADL ([@bib69]; [@bib71]; [@bib51]).

Since TGF-β and insulin signaling pathways act in parallel to regulate dauer formation, we examined whether members of the insulin signaling pathway also contribute to the developmental programming of *osm-9.* We examined *osm-9*p::*gfp* expression in animals carrying mutations in the *daf-2* insulin/IGF receptor homolog, *age-1* PI3K homolog, *pdk-1* 3-phosphoinositide-dependent kinase 1 ortholog, and *daf-16* forkhead FOXO transcription factor ([@bib19]; [@bib88]; [@bib39]; [@bib24]; [@bib54]; [@bib61]). We observed that mutations in *daf-2* and *age-1* significantly reduced GFP levels in ADL neurons of CON adults compared to wild-type, suggesting that insulin signaling is a positive regulator of *osm-9* expression ([Figure 3A](#fig3){ref-type="fig"}). However, the *pdk-1* mutant strain and two different mutations in *daf-16* FOXO, which functions downstream in insulin signaling, exhibited wild-type levels of GFP in ADL neurons ([Figure 3A](#fig3){ref-type="fig"}). Furthermore, we tested *osm-9*p::*gfp* expression in a *daf-12* NHR mutant strain, which has a potential binding site (GGTGTGAC) located 362 bp upstream of the *osm-9* translational start site ([Figure 2A](#fig2){ref-type="fig"}) ([@bib1]). Interestingly, the *daf-12* mutant also exhibited significantly decreased GFP in CON adults compared to wild-type ([Figure 3A](#fig3){ref-type="fig"}). We were unable to obtain postdauers from the *pdk-1, daf-16(m27)*, and *daf-12* strains to examine PD *osm-9*p*::gfp* expression. TGF-β and insulin signaling pathways converge onto DAF-12, which integrates environmental signals and regulates gene expression programs by binding to different ligands ([@bib44]; [@bib12]; [@bib90]). Our results suggest that insulin signaling, as well as DAF-12 NHR, does not play a role in the developmental programming of *osm-9*, but instead contributes to the positive regulation of constitutive *osm-9* expression. Together, these results suggest a model where TGF-β and insulin signaling, as well as DAF-12 NHR, promote constitutive *osm-9* expression in ADL neurons during favorable growth conditions, resulting in ascr\#3 avoidance in adult animals. In unfavorable conditions, reduced TGF-β signaling in conjunction with dauer formation results in the programmed down-regulation of *osm-9* in PD ADL neurons through the action of DAF-3 and DAF-5, resulting in the failure of adult animals to avoid ascr\#3 ([Figure 3C](#fig3){ref-type="fig"}).

*Mutator* proteins and nuclear RNAi silencing pathways play a role in the developmental programming of *osm-9* {#s2-5}
--------------------------------------------------------------------------------------------------------------

Although our data thus far strongly indicate that the developmental programming of *osm-9* is established by upstream regulatory sequences, the inability to rescue the ascr\#3 avoidance behavioral defect in PD adults of wild-type or *osm-9* mutants upon expression of *osm-9* coding sequences suggests that the coding sequence may also be a target of developmental programming ([Figure 1D](#fig1){ref-type="fig"}). In plants, fungi, and animals, short interfering RNAs (siRNAs) have been shown to act in *trans* to silence homologous sequences either by inhibiting transcription (transcriptional gene silencing, TGS) or through the destruction of mRNA (post-transcriptional gene silencing, PTGS) (reviewed in [@bib7]). To examine whether endogenous RNAi pathways play a role in the developmental programming of *osm-9,* we examined *osm-9*p::*gfp* expression in a subset of strains carrying mutations in genes with known functions in RNAi pathways ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These strains included animals mutant for components of the *Mutator* focus, a protein complex that localizes adjacent to P-granules and is thought to contribute to siRNA amplification in the germline ([@bib98]; [@bib67]). However, whether *Mutator* proteins form a complex in somatic tissue and their functions in neurons remain unclear. We found that mutations in five of the seven proteins known to associate with the *Mutator* focus (*mut-2/rde-3, mut-14, mut-15, mut-16*, and *rrf-1* RdRP) resulted in a significant increase in GFP expression in PD ADL neurons compared to CON ([Figure 4A](#fig4){ref-type="fig"}). In previous work, we identified low abundance siRNAs mapping to the *osm-9* locus with a bias for exon sequences ([@bib29]), indicative of siRNA biogenesis through the action of RdRPs such as RRF-1 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) ([@bib59]; [@bib75]). To confirm that endogenous RNAi pathways are contributing to the down-regulation of *osm-9* in PD ADL neurons, we again performed smFISH to measure *osm-9* mRNA abundance in ADL neurons of CON and PD adults carrying a mutation in the *mut-16* gene. For all three trials performed, we observed a significant increase in the mean and maximum fluorescence intensities of PD ADL neurons in *mut-16(mg461)* strain compared to wild-type ([Figures 1C](#fig1){ref-type="fig"} and [4B](#fig4){ref-type="fig"} and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). When the trials were combined, the *mut-16(mg461)* strain exhibited only a 7% change in mean fluorescence intensity of PD/CON ADL neurons compared to a 42% difference in wild-type ([Figure 4B](#fig4){ref-type="fig"}), indicating that functional MUT-16 is required for the full down-regulation of *osm-9* mRNA levels in PD ADL neurons. As a control, we also measured *gfp* mRNA abundance in the *mut-16* strain and observed no significant differences in mean and maximum intensity levels between CON and PD ADL neurons ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). Together, these results indicate a role for the *Mutator* proteins in the PD control of *osm-9* expression in ADL neurons.10.7554/eLife.11642.024Figure 4.Endogenous RNAi pathways regulate the developmental programming of *osm-9* expression and ascr\#3 avoidance behavior.(**A**) Percentage of ADL neurons expressing *osm-9*p::*gfp* in wild-type and strains carrying mutations in endo-RNAi genes. Data for additional mutant strains is found in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. N ≥ 2 trials; n ≥ 40 animals ([Figure 4---source data 1](#SD14-data){ref-type="supplementary-material"}). \* indicates mutant CON or PD significantly different from wild-type; One-way ANOVA with LSD posthoc correction, p\<0.05. (**B**) Quantification of *osm-9* mRNA in ADL neurons of *mut-16(mg461)* CON and PD using smFISH. The graphs represent individual mean fluorescence measurements for N = 3 biologically independent trials; n ≥ 129 neurons ([Figure 4---source data 2](#SD15-data){ref-type="supplementary-material"}). Maximum florescent measurements are found in [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}. Control *gfp* mRNA measurements are found in [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}. Medians are indicated. Comparison of means with S.E.M. of all trials for CON and PD in wild-type and *mut-16* is shown. \*p\<0.05, \*\*\*p\< 10^--14^, Student's t-test. (**C**) Log2 PD/CON ratio of ascr\#3 avoidance behavior in wild-type and strains carrying mutations in endo-RNAi genes. Data for ADL and ASI-specific expression of *mut-16* rescue are averages of two extrachromosomal lines. N ≥ 3 trials; n ≥ 60 animals ([Figure 4---source data 3](#SD16-data){ref-type="supplementary-material"}). \* indicates PD/CON ratio significantly different from wild-type; & indicates PD/CON ratio significantly different from *mut-16(mg461)*; One-way ANOVA, LSD posthoc correction, p\<0.05. All error bars represent S.E.M. Data for controls is found in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.024](10.7554/eLife.11642.024)10.7554/eLife.11642.025Figure 4---source data 1.Spreadsheet containing percentages of animals expressing *osm-9*p::*gfp* in ADL neurons in strains carrying mutations in genes with RNAi functions.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.025](10.7554/eLife.11642.025)10.7554/eLife.11642.026Figure 4---source data 2.Spreadsheet containing raw and normalized mean florescence intensities of *osm-9* smFISH probes in ADL neurons in *mut-16(mg461)* strain.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.026](10.7554/eLife.11642.026)10.7554/eLife.11642.027Figure 4---source data 3.Spreadsheet containing PD/CON ascr\#3 avoidance ratios for strains carrying mutations in genes with RNAi functions.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.027](10.7554/eLife.11642.027)10.7554/eLife.11642.028Figure 4---figure supplement 1.The ERGO-1/NRDE-3 endo-siRNA pathway contributes to the developmental programming of *osm-9* gene expression.Percentage of CON and PD adults that exhibited GFP in ADL neurons in additional mutant strains with functions in endo-RNAi and chromatin remodeling is shown. \* indicates CON or PD significantly different compared to wildtype; p\<0.05; One-way ANOVA with LSD posthoc correction. N ≥ 2 trials; n ≥ 40 animals. Error bars represent S.E.M. ([Figure 4---figure supplement 1---source data 1](#SD17-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.028](10.7554/eLife.11642.028)10.7554/eLife.11642.029Figure 4---figure supplement 1---source data 1.Spreadsheet containing percentage of animals expressing *osm-9*p::*gfp* in ADL neurons of additional strains carrying mutations in genes with RNAi and chromatin remodeling functions.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.029](10.7554/eLife.11642.029)10.7554/eLife.11642.030Figure 4---figure supplement 2.*osm-9* siRNAs map predominantly to exons.(**A**) Schematic of *osm-9* gene and regulatory regions. Exons are indicated by gray boxes. A tRNA (*B0212.t1*) and a non-coding RNA (*B0212.7*) are located in intron 12 of the *osm-9* locus (shown in purple). SiRNAs were sequenced from CON, PD, L3, and dauer whole animals in previous work ([@bib29]); those sequences mapping to the *osm-9* locus are indicated ([Figure 4---figure supplement 2---source data 1](#SD18-data){ref-type="supplementary-material"}). The black arrow indicates the siRNA mapping to the PD motif. (**B**) Characterization of siRNA length and location mapping to the *osm-9* locus for each developmental stage.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.030](10.7554/eLife.11642.030)10.7554/eLife.11642.031Figure 4---figure supplement 2---source data 1.Spreadsheet containing siRNA sequences mapping to the *osm-9* locus for CON, PD, larval L3, and dauer small RNA libraries.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.031](10.7554/eLife.11642.031)10.7554/eLife.11642.032Figure 4---figure supplement 3.*osm-9* mRNA levels quantified in *mut-16(mg461)* ADL neurons using smFISH.(**A**) Normalized maximum florescence levels in *mut-16(mg461)* CON and PD ADL neurons. Medians are indicated. \* indicates p\<0.05, \*\* p\<10^--4^, n.s. not significant, Student's t-test. (**B**) Graphs represent the average mean and maximum florescence levels of CON and PD ADL *mut-16(mg461)* neurons with *osm-9* mRNA smFISH probes in arbitrary brightness units (A.B.U.). (**C**) Graphs represent the average mean and maximum florescence background levels of CON and PD ADL *mut-16(mg461)* neurons. N = 3 biologically independent trials; n ≥ 129 neurons. Error bars are standard deviation ([Figure 4---figure supplement 3---source data 1](#SD19-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.032](10.7554/eLife.11642.032)10.7554/eLife.11642.033Figure 4---figure supplement 3---source data 1.Spreadsheet containing mean and maximum florescence intensities for *osm-9* smFISH probes in ADL neurons and worm backgrounds in *mut-16(mg461)* strain.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.033](10.7554/eLife.11642.033)10.7554/eLife.11642.034Figure 4---figure supplement 4.*gfp* mRNA levels are unaltered between CON and PD ADL neurons in *mut-16(mg461)* strain.(**A**) Quantification of *gfp* mRNA in ADL neurons of *mut-16(mg461)* CON and PD using smFISH. ADL neurons were identified by expression of *sre-1*p::*gfp*. The graphs represent individual mean and maximum fluorescence measurements for n = 10 neurons for 3 biologically independent trials. None of the comparisons between CON and PD within a trial are significantly different. (**B**) Graphs represent the average mean and maximum florescence levels of CON and PD ADL neurons in *mut-16(mg461)* with *gfp* mRNA smFISH probes in arbitrary brightness units (A.B.U.). (**C**) Graphs representing the average mean and maximum fluorescence levels of worm backgrounds. Error bars are standard deviation ([Figure 4---figure supplement 4---source data 1](#SD20-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.11642.034](10.7554/eLife.11642.034)10.7554/eLife.11642.035Figure 4---figure supplement 4---source data 1.Spreadsheet containing mean and maximum florescence intensities for *gfp* smFISH probes in ADL neurons and worm backgrounds in *mut-16(mg461)* strain.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.035](10.7554/eLife.11642.035)

To further investigate the role of *Mutator* proteins in the regulation of *osm-9* expression in PD animals, we tested whether the examined mutants affect the ascr\#3 avoidance behavior in CON and PD animals. Indeed, we found that mutations in genes associated with the *Mutator* complex, *mut-15* and *mut-16*, eliminated the difference in ascr\#3 avoidance between CON and PD adults ([Figure 4C](#fig4){ref-type="fig"}). The behavioral responses of *mut-2, mut-14* and *rrf-1* mutant strains also showed a trend towards disruption in the PD/CON ratio of ascr\#3 avoidance ([Figure 4C](#fig4){ref-type="fig"}). These results indicate that a subset of the *Mutator* proteins contributes to the plasticity of ascr\#3 avoidance behavior.

Since dsRNAs are actively transported between cells and tissue types in *C. elegans* ([@bib16]; [@bib37]; [@bib74]; [@bib47]; [@bib14]), we asked whether the *Mutators* act cell-autonomously to regulate ascr\#3 avoidance. To address this question, we expressed the *mut-16* cDNA under an ADL (*srh-220*p) or ASI (*gpa-4*p) specific promoter in the *mut-16(mg461)* strain and examined their ascr\#3 avoidance phenotypes ([Figure 4C](#fig4){ref-type="fig"}). We chose to examine MUT-16 function in ASI neurons as well, since *daf-7* and other TFG-β pathway genes are expressed in ASI ([@bib69]). We observed that cell-specific rescue of MUT-16 in ADL partially rescued the ascr\#3 avoidance in CON and PD animals ([Figure 4C](#fig4){ref-type="fig"}). In contrast, MUT-16 expression in ASI failed to rescue the avoidance behavior ([Figure 4C](#fig4){ref-type="fig"}). This result suggests that MUT-16 functions in ADL neurons to mediate ascr\#3 avoidance behavior due to developmental history.

Both the ERGO-1 and NRDE-3 endo-siRNA pathways require components of the *Mutator* focus and the ERI complex for the biogenesis of their associated siRNAs ([@bib15]; [@bib64]; [@bib20]; [@bib98]; [@bib67]; [@bib83]). ERGO-1 AGO associates with 26G-siRNAs to target mRNA transcripts in the cytoplasm and acts upstream of the 22G-siRNA-mediated NRDE nuclear RNAi silencing complex, which has been shown to promote heterochromatin formation at targeted gene loci in somatic tissue ([@bib28]; [@bib20]; [@bib27]; [@bib86]; [@bib5]; [@bib6]). Interestingly, we also observed a significant increase in PD GFP expression in ADL neurons in *ergo-1* AGO and nuclear RNAi silencing complex members, *nrde-3* AGO, *nrde-4,* and *nrde-1* mutants ([Figure 4A](#fig4){ref-type="fig"}). Moreover, the ERI complex also plays a role in the down-regulation of *osm-9* in PD ADL neurons ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These results indicate that the *Mutator* proteins, along with the endo-siRNA ERGO-1/NRDE pathway are playing a role in the developmental programming of *osm-9*. Consistent with a role for the ERGO-1 and NRDE pathways in the regulation of *osm-9* expression in PD adults, we found that mutations in *ergo-1* and *nrde-3* also resulted in the elimination of ascr\#3 avoidance differences between CON and PD adults ([Figure 4C](#fig4){ref-type="fig"}). Although we have not shown that *osm-9* is a direct target of endo-siRNA pathways, these results indicate that the *Mutator* proteins and ERGO-1/NRDE nuclear silencing pathways play a critical role in the developmental programming of *osm-9* and mediating the ascr\#3 avoidance behavior due to developmental history.

Chromatin remodeling pathways are required for maintenance of *osm-9* down-regulation in ADL neurons {#s2-6}
----------------------------------------------------------------------------------------------------

Thus far, our results have suggested a model where *osm-9* is regulated via transcriptional gene silencing, which would promote alteration of the chromatin state at the *osm-9* locus. To ask whether functional chromatin remodeling pathways are necessary for the differential expression of *osm-9* we examined *osm-9*p::*gfp* expression in CON and PD animals of strains carrying mutations in genes involved in chromatin remodeling ([Figure 5A](#fig5){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Although both SET-2 histone H3K4 methyltransferase and HDA-2 histone deacetylase act broadly to regulate histone modifications in the genome, their functions are antagonistic and correlate with gene activation or silencing, respectively ([@bib77]; [@bib31]). We found that mutations in *set-2* and *hda-2* resulted in a significant increase in GFP expression in PD ADL neurons compared to wild-type ([Figure 5A](#fig5){ref-type="fig"}). Thus, our results suggest the possibility that SET-2 and HDA-2 are targeting additional gene loci that play a role in the down-regulation of *osm-9* in PD ADL neurons. We also examined the role of ZFP-1 in the regulation of *osm-9* in PD adults, since it has been shown to bind chromatin and is predicted to play a role in the regulation of actively expressed genes through interactions with both chromatin remodeling and RNAi pathways ([@bib25]; [@bib3]). The known function of ZFP-1 is to negatively regulate RNA polymerase II elongation at loci of highly expressed genes ([@bib8]). Interestingly, we observed that a mutation in the *zfp-1* zinc finger protein gene eliminated the developmental programming of *osm-9*p::*gfp* expression in ADL neurons by significantly increasing GFP in PD adults ([Figure 5A](#fig5){ref-type="fig"}). Thus, ZFP-1 is an interesting candidate to play a role in the connection of the chromatin remodeling and the ERGO-1/NRDE-3 pathways in the developmental programming of *osm-9*.10.7554/eLife.11642.036Figure 5.Chromatin remodeling pathways are required for developmental programming of *osm-9* and ascr\#3 avoidance behavior.(**A**) Percentage of ADL neurons expressing *osm-9*p::*gfp* in wild-type and strains carrying mutations in genes with known chromatin remodeling functions. Data for *zfp-1(ok554)* represents average GFP expression of an *osm-9*p::*gfp* extrachromosomal array in two independent lines. N ≥ 3 trials; n ≥ 60 animals ([Figure 5---source data 1](#SD21-data){ref-type="supplementary-material"}). \* indicates CON or PD significantly different from wild-type; One-way ANOVA with LSD posthoc correction, p\<0.05. (**B**) Log2 PD/CON ratio of ascr\#3 avoidance behavior in wild-type and chromatin remodeling mutant strains. Data for ascr\#3 avoidance behavior of ADL-specific *zfp-1* rescue strains is an average of two extrachromosomal lines. N ≥ 3 trials; n ≥ 60 animals ([Figure 5---source data 2](#SD22-data){ref-type="supplementary-material"}). \* indicates PD/CON ratio significantly different from wild-type; Student's t-test, p\<0.05. & indicates PD/CON ratio significantly different from *zfp-1(ok554)*; Student's t-test, p\<0.01. Data for controls is found in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}. (**C**) Log2 enrichment of ZFP-1 at the *osm-9* DAF-3 binding site (DBS) and gene body in ADL neurons of CON and PD adults. Promoter regions for *egl-30* and *act-3* are positive controls ([@bib8]). Data was normalized to ZFP-1 binding to *gst-4* (negative control). N ≥ 2 biologically independent trials ([Figure 5---source data 3](#SD23-data){ref-type="supplementary-material"}). \* indicates enrichment significantly greater than background or between PD and CON, Student's t-test, p\<0.05. (**D**) Log2 normalized enrichment of DAF-3 SMAD at the *osm-9* DAF-3 binding site (DBS) in *mut-16(mg461)* and *zfp-1(ok554)* strains. *daf-8* and *daf-14* are positive and negative controls, respectively. Bar graph represents IP-qPCR data, normalized to DAF-3 binding to actin *act-2* promoter ([@bib62]), and adjusted to show enrichment of DAF-3 above background levels in *daf-3 (mgDf90)* strain. N = 3 biologically independent trials ([Figure 5---source data 4](#SD24-data){ref-type="supplementary-material"}). \* indicates enrichment significantly greater than background or between PD and CON, Student's t-test, p\<0.05. All error bars represent S.E.M.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.036](10.7554/eLife.11642.036)10.7554/eLife.11642.037Figure 5---source data 1.Spreadsheet containing percentages of animals expressing *osm-9*p::*gfp* in ADL neurons in strains carrying mutations in genes with chromatin remodeling functions.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.037](10.7554/eLife.11642.037)10.7554/eLife.11642.038Figure 5---source data 2.Spreadsheet containing PD/CON ascr\#3 avoidance ratios for strains carrying mutations in genes with chromatin remodeling functions.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.038](10.7554/eLife.11642.038)10.7554/eLife.11642.039Figure 5---source data 3.Spreadsheet containing ZFP-1 enrichment values in ADL neurons of wild-type CON and PD adults.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.039](10.7554/eLife.11642.039)10.7554/eLife.11642.040Figure 5---source data 4.DAF-3 immunoprecipitation data for the *osm-9, daf-8*, and *daf-14* loci in *mut-16(mg461)* and *zfp-1(ok554)* strains.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.040](10.7554/eLife.11642.040)

Next, we tested the CON and PD adult ascr\#3 avoidance response of strains carrying mutations in the genes *hda-2, set-2*, and *zfp-1.* We also examined the ascr\#3 avoidance response of *Heterochromatin protein 1* homolog mutant, *hpl-2*, since HPL-2 has been shown to play a role in the NRDE-mediated silencing of the *odr-1* gene during olfactory adaptation ([@bib38]). We observed that *hpl-2, set-2*, and *zfp-1* mutant strains exhibited an elimination or reversal of the wild-type PD/CON ascr\#3 avoidance responses, and *hda-2* trended towards a reduction in the PD/CON ascr\#3 avoidance behavior ([Figure 5B](#fig5){ref-type="fig"}). Together, these results suggest that functional chromatin remodeling pathways are required to maintain the down-regulation of *osm-9* in PD adults and mediate the ascr\#3 behavior due to developmental programming.

Since chromatin remodeling proteins act broadly to regulate genes, we asked whether *osm-9* is a direct target of chromatin change. ZFP-1 is known to bind chromatin; thus, we tested whether *osm-9* is a direct target of ZFP-1. We created strains expressing the *zfp-1* gene tagged with *gfp* specifically in ADL neurons in a *zfp-1(ok554)* mutant. We found that expression of ZFP-1 in ADL partially rescued ascr\#3 avoidance behavioral phenotype compared to the *zfp-1* mutant, indicating that the ZFP-1 transgene is functional ([Figure 5B](#fig5){ref-type="fig"}). Next, we performed chromatin immunoprecipitation of ZFP-1 from ADL neurons of CON and PD adults using α-GFP antibodies, followed by qPCR to test for enrichment of ZFP-1 at candidate gene loci. We found that ZFP-1 was significantly enriched at the *osm-9* DBS in PD adults, and enriched at *osm-9* coding sequences in both CON and PD ADL neurons ([Figure 5C](#fig5){ref-type="fig"}). We also examined ZFP-1 enrichment at the *act-3* and *egl-30* loci as positive and negative controls, respectively. These loci have been shown to be ZFP-1 targets using whole worm samples ([@bib8]); however, ZFP-1 enrichment of these loci in ADL neurons was unknown. These results are consistent with ZFP-1 playing a role in the transcriptional gene silencing of *osm-9* in ADL neurons of PD animals.

Together, our results indicate a role for DAF-3 SMAD, ZFP-1, and endogenous RNAi pathways in the down-regulation of *osm-9* in ADL neurons due to developmental history ([Figure 6](#fig6){ref-type="fig"}). Mutations in individual genes with TGF-β, chromatin remodeling, and RNAi functions resulted in an increase in *osm-9*p::*gfp* expression in PD ADL neurons when compared to wild-type, suggesting that these pathways may be coordinating to silence *osm-9*. Since dauer formation is required for *osm-9* down-regulation, we hypothesized that DAF-3 SMAD binds to the *osm-9* promoter during dauer and recruits ZFP-1 and RNAi machinery to the *osm-9* locus to maintain the silencing to adulthood. To test our hypothesis, we again immunoprecipitated DAF-3 in *mut-16(mg461)* and *zfp-1(ok554)* strains and performed qPCR to examine for DAF-3 enrichment at the *osm-9* DBS. If DAF-3 binds to *osm-9* first and recruits ZFP-1 and RNAi machinery, we would expect to observe DAF-3 enrichment at the *osm-9* PD motif in mutant PD adults. However, our results showed that DAF-3 enrichment was significantly decreased in *mut-16* and *zfp-1* backgrounds at the *osm-9* DBS compared to wild-type ([Figure 5D](#fig5){ref-type="fig"}), while remained enriched at the *daf-8* promoter (positive control). These results indicate that DAF-3 enrichment at the *osm-9* DBS in PD animals is dependent upon functional ZFP-1 and MUT-16. Although we cannot yet address the interactions of these pathways specifically in ADL neurons, our results are consistent with a model that DAF-3 SMAD, ZFP-1, and endogenous RNAi pathways are acting cooperatively to down-regulate *osm-9* as a result of developmental history.10.7554/eLife.11642.041Figure 6.DAF-3, ZFP-1, and RNAi machinery act cooperatively to down-regulate *osm-9* in postdauer ADL neurons.Model for developmental programming of *osm-9* gene expression as a result of developmental history. See Discussion for details.**DOI:** [http://dx.doi.org/10.7554/eLife.11642.041](10.7554/eLife.11642.041)

Discussion {#s3}
==========

The results described here support a model in which the differential expression of the *osm-9* TRPV channel gene is dependent upon a transcriptional gene silencing mechanism regulated by the TGF-β, chromatin remodeling, and endogenous RNAi pathways ([Figure 6](#fig6){ref-type="fig"}). During continuous growth of *C. elegans* larvae in favorable conditions, DAF-7 TGF-β binds to the DAF-1 and DAF-4 receptors, resulting in a signaling cascade where DAF-3 SMAD is inhibited ([@bib84]; [@bib63]). Based on our results, we hypothesize that insulin signaling, DAF-12 NHR, and unidentified \'activators\' act to promote transcription of *osm-9* in CON animals ([Figures 2](#fig2){ref-type="fig"}, [3A](#fig3){ref-type="fig"}). Expression of OSM-9 TRPV channel in ADL neurons of CON adults results in the avoidance of ascr\#3 pheromone ([Figure 1D](#fig1){ref-type="fig"}).

In stressful environments inducing dauer formation, *daf-7* TGF-β is not expressed, resulting in the de-repression of DAF-3. In this condition, we hypothesize that DAF-3, and possibly DAF-5, inhibit expression of *osm-9* in PD ADL neurons directly by binding to the PD motif ([Figures 2A](#fig2){ref-type="fig"}, [3A,B](#fig3){ref-type="fig"}). Our results showed that DAF-3 enrichment at the *osm-9* PD motif is dependent upon ZFP-1 ([Figure 5D](#fig5){ref-type="fig"}), which may be a direct interaction since both DAF-3 and ZFP-1 are enriched at the DBS in PD adults ([Figures 3B](#fig3){ref-type="fig"} and [5C](#fig5){ref-type="fig"}). ZFP-1 is also enriched in the gene coding sequence where it is predicted to promote chromatin remodeling and RNA polymerase II stalling ([Figure 5C](#fig5){ref-type="fig"}) ([@bib8]). Our results also show that endogenous RNAi pathways are required to maintain the transcriptionally silent state of *osm-9* and for DAF-3 enrichment at the PD motif, although we have not yet determined if this is due to direct and/or indirect targeting of the *osm-9* locus ([Figures 4A](#fig4){ref-type="fig"} and [6](#fig6){ref-type="fig"}). This maintained silent state of *osm-9* results in the failure to avoid ascr\#3 pheromone in postdauer adults ([Figures 1D](#fig1){ref-type="fig"} and [6](#fig6){ref-type="fig"}). Thus, we postulate that phenotypic plasticity of olfactory behavior in wild-type adults is dependent upon developmental history, through modulation of *osm-9* gene expression by TGF-β, endogenous RNAi, and chromatin remodeling pathways.

TGF-β and insulin signaling connect environmental conditions to regulation of *osm-9* {#s3-1}
-------------------------------------------------------------------------------------

In our previous work, we identified 2127 genes that exhibited altered expression levels as a consequence of passage through the dauer stage ([@bib30]). One question that arose from this observation was how the dauer developmental signal results in establishment of tissue-specific programmed changes in gene expression. DAF-3 SMAD and DAF-5 SNO/SKI are expressed throughout the worm and are required for dauer formation in unfavorable conditions ([@bib63]; [@bib11]). Here, we argue that DAF-3 and DAF-5 not only promote dauer formation, but also establish altered expression levels of genes due to developmental programming. First, we showed that the differential expression of *osm-9* is dependent upon functional TGF-β signaling during dauer formation, and not just upon passage through the dauer stage ([Figure 3A](#fig3){ref-type="fig"}). In addition, we have shown that DAF-3 binds to the PD motif, and is required for the down-regulation of *osm-9* in PD ADL neurons ([Figures 3A,B](#fig3){ref-type="fig"}). Direct regulation by DAF-3 is an attractive model for how developmental history can result in established gene expression changes for target genes such as *osm-9*. Moreover, competitive binding to the PD motif between DAF-3 and other cell or tissue specific transcription factors can make the developmental programming specific to a cell type (such as ADL) without affecting expression in other cell types (such as AWA). A similar model of regulation by DAF-3 has been postulated for the *myo-2* gene in the pharynx ([@bib82]). TGF-β signaling has also been shown to regulate neuronal receptor genes based on environmental cues via DAF-3-dependent and independent mechanisms in ASI, AWC, and interneurons ([@bib56]; [@bib42]; [@bib48]). Since 977 genes in the genome contain the PD motif and the DAF-3 binding site is enriched in chemoreceptor genes ([@bib46]), we predict that DAF-3 might play a larger role in broadly establishing gene expression changes in response to environmental cues. We are currently testing our model by identifying additional proteins that bind to the PD motif in the *osm-9* gene and by examining expression patterns of other genes containing the PD motif.

Endogenous RNAi pathways in neurons regulate phenotypic plasticity {#s3-2}
------------------------------------------------------------------

Our results indicate that endogenous RNAi pathways regulate neuronal gene expression in response to developmental history. Temporal regulation of neuronal gene expression has been shown previously in AWC neurons, whereby DAF-3 establishes expression levels of chemoreceptor genes during early larval stages that are maintained in adults by the homeobox transcription factor ortholog, HMBX-1 ([@bib42]). We propose a similar model where DAF-3/DAF-5 contributes to the down-regulation of *osm-9* in animals that enter the dauer stage, which is dependent upon functional RNAi pathways ([Figure 5D](#fig5){ref-type="fig"}). At this time, we are unable to distinguish whether the requirement of MUT-16 for DAF-3 enrichment at the PD motif is indirect or direct. Our results are consistent with MUT-16 contributing to the positive regulation of *daf-3* expression, silencing of *osm-9* expression, or both ([Figures 4](#fig4){ref-type="fig"} and [5D](#fig5){ref-type="fig"}). We detected lowly abundant siRNAs homologous to *osm-9* in whole animals ([@bib29]); however, the *daf-3* locus is targeted by significant numbers of siRNAs that require MUT-16 and CSR-1 AGO for biogenesis ([@bib9]; [@bib98]), which is predicted to positively regulate gene expression by promoting a euchromatic chromatin state at target loci ([@bib97]). Furthermore, we find that components of the *Mutator* focus play a significant role in the differential regulation of *osm-9* in ADL neurons and modulation of ascr\#3 avoidance behavior ([Figure 4](#fig4){ref-type="fig"}). To date, the localization and function of *Mutator* proteins in somatic tissue has been unclear, and some evidence suggests that *Mutator* component MUT-14 only functions within the germline ([@bib98]; [@bib66]). However, MUT-2, MUT-7, and the NRDE silencing complex have been shown to play a role in olfactory adaptation mediated by AWC neurons ([@bib38]), and our results indicate that the *Mutator* proteins, MUT-2, MUT-14, MUT-15, and MUT-16, and the associated RdRP RRF-1, function to regulate *osm-9* expression in ADL ([Figure 4A](#fig4){ref-type="fig"}). In addition, we show that MUT-15, MUT-16, and RRF-1 contribute to modulation of ascr\#3 avoidance behavior, and that MUT-16 is required in ADL neurons for the plasticity of ascr\#3 avoidance due to developmental history ([Figure 4B](#fig4){ref-type="fig"}).

Moreover, we provide evidence that the ERGO-1/NRDE nuclear silencing pathways contribute to the maintained silencing of *osm-9* in postdauer animals ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Since the NRDE complex is associated with transcriptional gene silencing, our results suggest that *osm-9* regulation in PD ADL neurons by NRDE is more likely to be a direct interaction. We hypothesize that *Mutator*-amplified siRNAs direct the targeting of the NRDE nuclear silencing complex to the *osm-9* locus, which results in transcriptional gene silencing of *osm-9* in PD ADL neurons. Furthermore, we speculate that siRNAs generated to target the endogenous *osm-9* locus could also direct targeting of the NRDE complex to the ADL-specific *osm-9* rescue transgene, resulting in the transcriptional silencing of the *osm-9* coding sequence in the absence of the upstream regulatory sequences ([Figure 1D](#fig1){ref-type="fig"}). Although we have not shown directly that NRDE-3 targets *osm-9*, regulation by the NRDE complex is an attractive hypothesis, since we have evidence of both RNAi and transcriptional silencing mechanisms playing a role in regulating *osm-9* ([Figures 1A,B](#fig1){ref-type="fig"}, [2,](#fig2){ref-type="fig"} and [4A](#fig4){ref-type="fig"}).

Our results showing that the ERGO-1/NRDE pathway contributes to the down-regulation of *osm-9* in PD adults raises new questions of how RNAi pathways regulate endogenous genes due to developmental history. NRDE-3 must be bound by a siRNA to enter the nucleus and target nascent RNAs ([@bib28]; [@bib27]; [@bib5]; [@bib6]), which suggests a mechanism for selective siRNA amplification in animals with different developmental histories. This prediction is consistent with our previous findings that PD and CON animals have significantly different small RNA profiles ([@bib29]). Further investigation of ERGO/NRDE pathways will be necessary to understand their interactions and roles in the maintenance of gene silencing due to developmental programming.

Developmental programming of *osm-9* could contribute to environmental adaptation {#s3-3}
---------------------------------------------------------------------------------

Our results have led us to question why *osm-9* is down-regulated in PD animals. Dauer pheromone has been shown to have both primer and releaser effects on *C. elegans* larval development and adult behaviors, respectively (reviewed in [@bib43]). We speculate that it is advantageous to down-regulate *osm-9* expression in animals that have entered the dauer stage. One possibility is that decreased *osm-9* expression during dauer results in a failure to respond to ascr\#3, allowing worms to exit the dauer stage in areas of local high pheromone concentration. *C. elegans* animals that enter the dauer stage due to high population density and do not disperse would have their dauer exit suppressed by the local high concentrations of pheromone ([@bib23]; [@bib21]). Although ADL has not been implicated in dauer recovery to date, down-regulation of *osm-9* could allow dauer animals to become more sensitive to changes in their environment and allow faster dauer recovery when conditions improve ([@bib26]). Second, failure to avoid high concentrations of ascr\#3 in postdauer hermaphrodites may serve as a mechanism for increased outcrossing in stressful environments. *C. elegans* males recover from long periods in the dauer stage at higher rates than hermaphrodites, increasing the opportunities for outcrossing in a postdauer population ([@bib53]). We postulate that down-regulation of *osm-9* in postdauer hermaphrodites suppresses their dispersal to avoid high concentrations of pheromone, further increasing the opportunities for outcrossing. Thus, we speculate the differential regulation of *osm-9* via developmental programming mechanisms potentially serves to suppress both the primer and releaser effects of pheromone in order to promote survival and reproduction in stressful environmental conditions.

Materials and methods {#s4}
=====================

*C. elegans* strains {#s4-1}
--------------------

All *C. elegans* strains were generated and maintained by using standard methods ([@bib4]; [@bib79]). Worm strains used in this study are described in [Supplementary file 1](#SD25-data){ref-type="supplementary-material"}. All strains were grown at 20°C or 15^o^C (for temperature sensitive strains) on NGM plates seeded with *E. coli* OP50. Developmentally synchronized control and postdauer adults were staged using egg plates as previously described ([@bib30]; [@bib58]). Controls were obtained by bleaching gravid adults to NGM plates without egg white. To induce worms by high crude pheromone concentrations, dauer formation assays were performed as previously described ([@bib55]). Strains with dauer deficient phenotypes were exposed to a starvation protocol and grown at 25°C to produce dauers. To induce dauer formation by starvation, well-fed worms were plated onto seeded 100mm NGM plates, and were monitored daily for the depletion of food and the appearance of dauers. Dauer larvae were obtained by treating starved plates with 1% SDS for 24 hr.

Imaging of *osm-9*p::*gfp* expression {#s4-2}
-------------------------------------

*osm-9*p::*gfp* and *unc-122*p::*dsRed* were cloned into plasmids and microinjected as an extrachromosomal array at a concentration of 30 ng/μL into N2 and integrated into the genome using UV irradiation. The integrated *osm-9*p::*gfp* array (*pdrIs1*) was genetically crossed into mutant backgrounds for imaging. *osm-9*p::*gfp* was directly microinjected as an extrachromosomal array into *zfp-1(ok554)* strain since the integrated transgene and gene locus were closely linked. Animals were visualized on a Leica CTR550 microscope with a Hamamatsu C10600 camera. Adult animals were dye-filled with 2 mg/mL DiD for two hours prior to imaging in order to identify ADL neurons. A minimum of twenty animals was examined for CON and PD conditions for each strain over at least three trials on separate days. All animals were imaged as young adults, 24 hr after L4. Primer sequences for *osm-9*p::*gfp* cloning are located in [Supplementary file 2](#SD26-data){ref-type="supplementary-material"}.

Mutagenesis {#s4-3}
-----------

Mutagenesis of the *osm-9*p::*gfp* transgene was performed using the QuickChange XL kit (Agilent) following the specifications of the manufacturer. Deletions of the *osm-9* promoter were made by cloning individual promoter fragments into a plasmid containing *gfp*. All deletion and mutagenesis transgenes were microinjected as extrachromosomal arrays with co-injection marker *unc-122*p::*dsRed* into N2 at a concentration of 30 ng/μL and imaged as described above. Primer sequences are located in [Supplementary file 2](#SD26-data){ref-type="supplementary-material"}.

Single molecule fluorescent in situ hybridization {#s4-4}
-------------------------------------------------

smFISH experiments were performed essentially as described ([@bib36]). Briefly, CON and PD adults of the SH239 *otIs24 \[sre-1p::gfp*\] strain and SH265 *mut-16(mg461) I; otIs24* were fixed in 10% formaldehyde for 45 min followed by incubation in 70% ethanol for at least 48 hrs at 4°C. Fixed worms were hybridized overnight at 30°C with a set of 32 Stellaris *gfp* smFISH probes (labeled with Quasar 670 flourophores, Biosearch Technologies) (a kind gift from Oliver Hobert) and a set of 48 Stellaris *osm-9* smFISH probes (labeled with Quasar 570 flourophores, Biosearch Technologies). *osm-9* probe sequences are available upon request. Worms were mounted on slides using VectaShield H-1000 (Vector Laboratories).

Images for *osm-9* smFISH experiements were acquired on a Leica DM5500 B microscope coupled with a Leica CTR5500 electronic box mounted with a Hamamatsu Digital Camera C10600 ORCA R^2^. The intensity of *osm-9* smFISH signals in the ADL neuron, as demarcated by *otIs24*, from maximally projected images of z-stacks (0.2 μM stacks) was quantified using the Leica LAS AF 3.1.0 software. Images of the *gfp* smFISH signals were taken on a Zeiss Axio Observer Z1 motorized microscope with Hamamatsu Orca Flash 4.0 LT camera followed by quantification on Image J. Exposure times were consistent within a trial, and images were not processed before analysis. Fluorescence quantification was performed blindly by two people. Normalization for individual measurements was performed by dividing each measurement by the median of the control samples for each trial. Since the signal to noise ratio was low (mean background \> (mean -- 2StDev)), we did not subtract background values from fluorescence measurements.

Behavioral assays {#s4-5}
-----------------

The drop test acute avoidance response assay was performed using 100 nM ascr\#3, M13 buffer (negative control), and 1M glycerol (positive control) as previously described ([@bib33]; [@bib34]). Animals were tested off food. For each strain, a minimum of three trials were performed on separate days, with a minimum of 30 animals assayed for each trial. The ascr\#3 avoidance behavior was normalized by subtracting the proportion of animals responding to M13 buffer from the proportion of animals responding to ascr\#3. For [Figure 1D](#fig1){ref-type="fig"}, the normalized avoidance response for each trial was averaged across trials for the graphs. For [Figures 3C](#fig3){ref-type="fig"}, [4C,](#fig4){ref-type="fig"} and [5B](#fig5){ref-type="fig"}, graphs represent averages of PD/CON ratios calculated for each trial. M13 and 1M glycerol avoidance data for each strain is found in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}.

Neuron-specific rescue strains {#s4-6}
------------------------------

Overlap extension PCR ([@bib32]) with Phusion DNA polymerase (NEB) was used to construct *sre-1*p*::mut-16 cDNA::gfp, gpa-4*p*::mut-16 cDNA::gfp, sre-1*p*::zfp-1 cDNA::gfp, gpa-4*p*::zfp-1 cDNA::gfp*, and *sre-1*p*::osm-9 cDNA::gfp* transgenes. To make *sre-1*p*::mut-16 cDNA::gfp*, 3 kb of the *sre-1* promoter, the *mut-16* cDNA (using a cDNA library prepared from total RNA of a mixed N2 population as the template), and the *gfp* gene (using Fire vector pPD95.75 as the template) were amplified separately. A final fused PCR was amplified using primers containing *Xma*I and *Sbf*I sites, digested with *Xma*I and *Sbf*I and cloned into pUC19. *gpa-4p::mut-16 cDNA::gfp* was constructed with the same method, except with 3 kb of the *gpa-4* promoter. ADL and ASI-specific *zfp-1* transgenes were cloned into pCR TOPO XL (Life Technologies) following the instructions of the manufacturer. The fragment consisting of *sre-1p::osm-9 cDNA::gfp* was microinjected as a linear PCR at 30 ng/μl into N2 and *osm-9(ky10)*. Plasmids containing the *zfp-1* and *mut-16* neuron-specific rescues were microinjected ([@bib52]) into N2, *mut-16(mg461)*, or *zfp-1(ok554*) animals at 50 ng/μl along with an *unc-122p::dsRed* co-injection marker (30 ng/μl) or genetically crossed into the desired mutant background. Primer sequences are located in [Supplementary file 2](#SD26-data){ref-type="supplementary-material"}.

DAF-3 immunoprecipitation and qPCR {#s4-7}
----------------------------------

A packed pellet of worms (\~100 μL) consisting of staged larval L2, dauer, CON, or PD animals were subjected to chromatin immunoprecipitation as described using 2% paraformaldehyde as the crosslinking reagent ([@bib30]; [@bib29]). Preparation of the lysate was done using a Sonic Dismembrator Model 100 (Fisher Scientific) and immunoprecipitation was performed using 5 μl of α-DAF-3 antibody (Novus Biologicals NB100-1924). DAF-3 IP was performed for three biologically independent samples for each condition. To determine if DAF-3 was bound to the *osm-9* PD motif, quantitative PCR was performed with 2--3 μl of the DAF-3 IP DNA using iTaq Universal SYBR Green Supermix (BioRad) following the recommendations of the manufacturer. Ct values were normalized using the *act-2* upstream regulatory sequences as previously described ([@bib62]). Primer sequences are located in [Supplementary file 2](#SD26-data){ref-type="supplementary-material"}.

ZFP-1 immunoprecipitation and qPCR {#s4-8}
----------------------------------

A packed pellet of worms (\~500 μL) consisting of control and postdauer young adult populations of SH198 *zfp-1(ok554) III; pdrEx22 \[sre-1*p::*zfp-1 cDNA::gfp; unc-122*p::*dsRed*\], SH261 *mut-16(mg461) I; pdrEx22*, and SH262 *daf-3(mgDf90) X; pdrEx22* were subjected to chromatin immunoprecipitation as described previously using 2% paraformaldehyde as the crosslinking agent ([@bib30]; [@bib29]). Lysates were prepared using a Sonic Dismembrator Model 100 (Fisher Scientific). ZFP-1 immunoprecipitations were performed using 25 μl of GFP-nAb Magnetic beads (Allele Biotech) following the recommendations of the manufacturer. To determine ZFP-1 enrichment at gene loci, quantitative PCR was performed using 5 μL of the precipitated DNA using iTaq Universal SYBR Green Supermix (BioRad). Ct values for ZFP-1 enrichment were normalized to the *gst-4* gene, which is not a known target of ZFP-1. Promoter sequences for *egl-30* and *act-3* were positive controls for ZFP-1 enrichment since they have been identified as ZFP-1 targets ([@bib8]). Primer sequences are located in [Supplementary file 2](#SD26-data){ref-type="supplementary-material"}.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000002National Institutes of Health NIGMS 5-F32-GM83593 to Sarah E Hall.

-   http://dx.doi.org/10.13039/100000001National Science Foundation IOS 0842452 to Piali Sengupta.

-   http://dx.doi.org/10.13039/501100003725National Research Foundation of Korea 2012R1A1A2009385 to Kyuhyung Kim.

-   DGIST R&D Program of the Ministry of Science, ICT and Future Planning 15-BD-06 to Kyuhyung Kim.

-   http://dx.doi.org/10.13039/100000048American Cancer Society 1092124-56171:IRG1105201 to Sarah E Hall.

-   http://dx.doi.org/10.13039/100007126Syracuse University Reneé Crown University Honors Program Lynn Parker Award to Mailyn A Nishiguchi.

We would like to thank Rebecca Butcher for the ascr\#3 used for these experiments, Oliver Hobert for the generous gift of the *gfp* smFISH probes, Nikolaos Stefanakis and Scott Neal for assistance with the smFISH protocol, Austin Hager for chemotaxis data in [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}, Torsten Woellert and George Langford for use of their microscope, Michael O'Donnell for critical reading of the manuscript, and CGC for strains (NIH Office of Research Infrastructure Programs, P40 OD010440). This work was supported by NIH NIGMS 5-F32-GM83593 and American Cancer Society 1092124-56171:IRG1105201 awards to SEH, Crown Wise Lynne Parker Scholar Award to MN, DGIST R&D Program of the Ministry of Science, ICT, and Future Planning (16-BD-06) to KK, and NSF IOS 0842452 to P.S.

Additional information {#s5}
======================

The authors declare that no competing interests exist.

JRS, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

MCO, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

MAN, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

KK, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

PS, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

SEH, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

Additional files {#s6}
================

10.7554/eLife.11642.042

###### List of *C. elegans* strains used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.11642.042](10.7554/eLife.11642.042)

10.7554/eLife.11642.043

###### Excel file containing primer sequences used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.11642.043](10.7554/eLife.11642.043)

Major datasets {#s7}
--------------

The following previously published dataset was used:

Hall SE, Chirn GW, Lau NC, Sengupta P,2013,sRNA profiles of control adults, postdauer adults, larva L3, and dauer stages of C. elegans,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE33313>,Publicly available at NCBI Gene Expression Omnibus (accession no: GSE33313)
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Developmental programming modulates olfactory behavior in *C. elegans* via endogenous RNAi pathways\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

Developmental imprinting is an important process by which early life experiences of an animal stably alters the organism\'s gene expression and thus physiology and perhaps psychology for life. The question of what molecular mechanisms trigger and maintain this changes is outstanding. In mammals, the circuits involved and their outputs are complex and poorly understood and thus invertebrate models with very simple circuits underlying imprinted behaviors are very attractive. This paper shows that an imprinted locus can be stably regulated by developmental experience by the action of the repressive co-SMAD DAF-3 binding to a specific region of the promoter. The authors used the *osm-9::gfp* as a convenient marker to mark this channel in the ADL neuron. Upon dauer formation via any of 3 mechanisms, the *osm-9* signal in the ADL neuron is eliminated. This ion channel is central to the olfactory sense in the worm, and consistent with this, the postdauer animals show reduced responses to a worm pheromone asc\#3. The *osm-9::gfp* approach is clever, and the paper makes full use of worm genetics to narrow down the promoter region, and the mechanisms of transcriptional silencing in these animals. All three reviewers recognized the importance of the question and agree that the authors took the right approach to answer this question.

However, the reviewers did have some technical concerns that need to be addressed. We would like to invite the authors to respond to these questions in their resubmission.

First, the ChIP experiment lacks obvious controls. Second, the ChIP experiment lacks cellular resolution, which is important since the locus in question is expressed widely as is DAF-3. The authors also show that the repression of the reporter gene and the postdauer specific behavior requires the mutator locus and chromatin remodeling genes. The evidence for the involvement of these genes is purely genetic. The interpretation of these findings are not clear: could repression of OSM-9 be due to increased transgene silencing in the PD ADL neuron? Could the repression be due to increased DAF-3 down stream of mutator-induced repression of a DAF-3 repressor? They implicate direct interaction of the zinc finger protein ZFP-1 in repression of the promoter by showing it binds directly to the promoter but this does not prove the mutator locus is required for this factor\'s activity in the PD ADL.

Thus, to substantiate the claims the authors would need to perform the following experiments:

Experiment to link DAF-3 to siRNA by performing the [Figure 3B](#fig3){ref-type="fig"} ChIP in mutator/chromatin remodeling mutant backgrounds.

Experiment to provide cellular resolution to the repression: express *sre-1::daf-3*::3XFLAG and redo ChIP.

Experiment to link ZFP-1 [Figure 5C](#fig5){ref-type="fig"} to the mutator and *daf-3*. They should have separated control from PD and looked at ZFP-1 occupancy of the promoter/ gene in *daf-3* mutants, mutator mutant (*mut-16*) as well to ask if DAF-3 is required for ZFP-1 occupancy. This would provide at least an indirect link. Not perfect but approachable.

Experiment to link endosiRNA pathway to PD negative regulation of *osm-9* would be to do the smFISH in control vs. PD in *mut-16* background (at least one of the endosiRNA mutants).

ChIP experiments need negative controls: IP from the null background to examine non-specific IP; IP of an unaffected gene (*act-2* was not vetted anywhere in the paper).

Important but omitted: Better description of the *osm-9* endosiRNA profiles from control and PD... where do they map in the *osm-9* gene?

Other questions include:

Avoidance of the pheromone ascr\#3 is tested, with the expected results. Can the authors provide control data to show that chemotaxis to unrelated molecules is normal? How specific is this effect-only to ascr\#3 or other pheromones and nonpheromonal odorants?

Related to this, how pervasive is the effect of the postdauer experience on worm biology? The authors are using *osm-9::gfp*, allowing them to focus on a few neurons. But are other parts of the chemosensory circuit also affected by the developmental events? Some evidence for specificity would greatly enhance the conclusions.

In the last line of the subsection "The TGF-β pathway negatively regulates *osm-9* in postdauer animals" [Figure 3D](#fig3){ref-type="fig"} should be 3C.

[Figure 5B](#fig5){ref-type="fig"} authors should consider using an ampersand, as in [Figure 4B](#fig4){ref-type="fig"},

to indicate that the *zfp-1(ok554)::Ex(ADLp::zfp-1::gfp)* value differs from that of *zfp-1(ok554).*

In the first paragraph of the Discussion the authors may wish to reconsider their use of the term \"transcriptional licensing\".

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Developmental programming modulates olfactory behavior in *C. elegans* via endogenous RNAi pathways\" for further consideration at *eLife*. Your revised article has been favorably evaluated by a Senior editor, a Reviewing editor, and three reviewers. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

As you can see, reviewer 2 is still somewhat concerned by the responses provided in the last round of revision. Reviewer 3 has a specific request. Please address reviewer 3\'s request. Please also add the ADL-specific IPs results since you probably have had time to finish that. Once you have these results, we will consider the revised manuscript and provide a swift decision.

*Reviewer \#1:*

The paper is does not pose any concerns. It does a good job of describing a very intriguing mechanism whereby a ubiquitous SMAD signal coupled with endogenous RNAi programs endow a neuron with plasticity. This is, as far as I know, only the second instance of an environmental cue acting via endogenous RNAi to program plasticity. Very nice.

*Reviewer \#2:*

Sims et al. provide a revision that attempts to delve further into the mechanism by *osm-9* gene regulation is modulated after early life stress. Responses to the concerns that I raised in the initial review are acceptable. I continue to find the observations that developmental history reduces *osm-9* expression, and concomitant reduced sensitivity to pheromone, very interesting. Unfortunately, many of the experiments requested by one of the reviewers produced equivocal or incomplete results. In some cases, necessary controls were unavailable due to technical problems and time constraints for resubmission to *eLife*. Here is a case where the paper was actually weakened, rather than strengthened, through peer review. My sense is that there are a lot of interesting observations here, but there is a lack of conclusive data to support the mechanistic conclusions shown in [Figure 6](#fig6){ref-type="fig"}. The options would be to give the authors additional time to complete the missing experiments mentioned in the response to reviewers. Alternatively, the authors could back off from the strong conclusions, remove the incomplete data, and resubmit a paper more narrowly focused on the observations that seem robust, but removing the speculation not supported by the data.

*Reviewer \#3:*

The comments I made in my earlier review have been satisfactorily addressed, except for one point that is not clear:

\"The rescue strain expressing ADL-specific ZFP-1 is not significantly different in its behavior. In the manuscript, we describe the ascr\#3 avoidance of the rescue strain as \"partially restored\".

If the rescue strain is not significantly different from the mutant, then it\'s not clear that it has been partially restored.

As for the comments made by the other reviewers, it seems that the manuscript has been improved. If it would be possible to improve the manuscript much more with a modest extension of the time line, then this would be OK with me.

10.7554/eLife.11642.047

Author response

\[...\] However, the reviewers did have some technical concerns that need to be addressed. We would like to invite the authors to respond to these questions in their resubmission.

First, the ChIP experiment lacks obvious controls. Second, the ChIP experiment lacks cellular resolution, which is important since the locus in question is expressed widely as is DAF-3. The authors also show that the repression of the reporter gene and the postdauer specific behavior requires the mutator locus and chromatin remodeling genes. The evidence for the involvement of these genes is purely genetic. The interpretation of these findings are not clear: could repression of OSM-9 be due to increased transgene silencing in the PD ADL neuron? Could the repression be due to increased DAF-3 down stream of mutator-induced repression of a DAF-3 repressor? They implicate direct interaction of the zinc finger protein ZFP-1 in repression of the promoter by showing it binds directly to the promoter but this does not prove the mutator locus is required for this factor\'s activity in the PD ADL.

Thus, to substantiate the claims the authors would need to perform the following experiments:

Experiment to link DAF-3 to siRNA by performing the [Figure 3B](#fig3){ref-type="fig"} ChIP in mutator/chromatin remodeling mutant backgrounds.

We agree with the reviewers that the cell-specificity of DAF-3 enrichment, and its dependence upon ZFP-1 and RNAi pathways, is important to the validity of our model of *osm-9* regulation. Since a strain carrying *sre-1*p::*daf-3::gfp* did not exist, we 1) cloned the ADL-specific *daf-3* transgene, 2) created stable, extrachromosomal transgene lines, 3) bulked the strains to obtain synchronous stage-specific populations, and 4) performed the IP-qPCR. In order to complete this experiment in a timely manner, we chose to inject wild-type, *mut-16*, and *zfp-1* strains directly with the transgene. We regret that we were unable to obtain a wild-type transgenic line on our first attempt, so that the data may be included in this resubmission. We now have this strain, and are performing the ADL-specific DAF-3 IPs currently. If the editors feel that this experiment is pivotal to our manuscript acceptance, we would happily include this data if granted an extension. We approximate \~ 3 weeks would be necessary to complete the ADL-specific IPs in wild-type animals. Instead, we have included the original DAF-3 enrichment data using an anti-DAF-3 antibody ([Figure 3B](#fig3){ref-type="fig"}) with new positive and negative controls. Our results indicate that DAF-3 enrichment at the potential DAF-3 binding site is significantly higher than CON adults. This observation is consistent with our model that DAF-3 binds *osm-9* after dauer to facilitate silencing.

In [Figure 6B](#fig6){ref-type="fig"}, we show ADL-specific DAF-3 enrichment in *mut-16* and *zfp-1* mutant backgrounds as requested. We were able to detect DAF-3 enrichment above background for the positive control in *zfp-1*, indicating that our experiment was successful. Interestingly, the results of this experiment indicate the novel finding that DAF-3 enrichment is dependent upon ZFP-1 activity. In addition, our data showed that both DAF-3 and ZFP-1 bind to the DAF-3 binding site region ([Figures 3B](#fig3){ref-type="fig"} and [5C](#fig5){ref-type="fig"}), suggesting the possibility of a direct interaction between these two proteins. However, we did not see enrichment of DAF-3 in the *mut-16* background, even at the positive control locus ([Figure 6B](#fig6){ref-type="fig"}). This observation could be due to experiment failure, or alternatively, could reflect the requirement of RNAi pathways to regulate *daf-3* expression as the reviewers suggested. Biogenesis of siRNAs mapping to the *daf-3* locus require functional MUT-16 and CSR-1 proteins (Zhang et al. 2011, Claycomb et al. 2009). Since CSR-1 AGO (bound by MUT-16 amplified siRNAs) promotes gene expression, we hypothesize that *daf-3* expression is decreased in a *mut-16* background. We have preliminary qRT-PCR data that support this hypothesis using mRNA from whole animals; however, additional experiments would be needed to examine MUT-16 dependent *daf-3* expression in ADL specifically. Our overall results cannot distinguish whether RNAi pathways affect *osm-9* regulation by promoting *daf-3* expression, silencing *osm-9* expression, or both. Our results examining the contribution of the NRDE complex to *osm-9* regulation, which promotes transcriptional gene silencing, is consistent with RNAi pathways acting to silence *osm-9* expression in PD ADL neurons and is not consistent with its potential regulation of *daf-3*. Thus, our current model is that RNAi pathways promote *daf-3* expression and silence *osm-9* expression through the action of different Argonaute proteins in PD ADL neurons. Our new model of *osm-9* regulation predicts that DAF-3 and ZFP-1 act cooperatively at the *osm-9* promoter to promote silencing.

*Experiment to provide cellular resolution to the repression: express sre-1::DAF-3::3XFLAG and redo ChIP.*

*Experiment to link ZFP-1 [Figure 5C](#fig5){ref-type="fig"} to the mutator and daf-3. They should have separated control from PD and looked at ZFP-1 occupancy of the promoter/ gene in daf-3 mutants, mutator mutant (mut-16) as well to ask if DAF-3 is required for ZFP-1 occupancy. This would provide at least an indirect link. Not perfect but approachable.*

Again, we agree with the reviewers that this is an important experiment to test our model of *osm-9* regulation. First, we examined ZFP-1 enrichment at the *osm-9* promoter and gene body in CON and PD wild-type animals. We found that ZFP-1 binds to the *osm-9* gene body in both populations, but shows significant enrichment at the DAF-3 binding site in PD compared to CON ([Figure 5C](#fig5){ref-type="fig"}). This interesting result suggests the possibility that ZFP-1 and DAF-3 may be interacting directly in PD ADL neurons to promote silencing of *osm-9*. Our results showing that DAF-3 enrichment is dependent upon ZFP-1 supports this hypothesis ([Figure 6B](#fig6){ref-type="fig"}). We also examined ZFP-1 enrichment at the *osm-9* locus in *mut-16* and *daf-3* strains, but we were unable to detect ZFP-1 enrichment above background for the positive controls (Figure 6---figure supplement 1). Since the *sre-1*p::*zfp-1::gfp* transgene was genetically crossed into these strains and worked well in the *zfp-1* background ([Figure 5C](#fig5){ref-type="fig"}), we suspect that our unsuccessful experiment in the mutant strains was due to the presence of the endogenous ZFP-1 protein out-competing our tagged version. Ideally, we would need to generate *zfp-1; daf-3* and *zfp-1; mut-16* double mutants carrying the transgene to test this hypothesis, but we did not have the time. However, we were able to show that ZFP-1 differentially binds at the *osm-9* locus in ADL neurons due to developmental history, and contributes to the down-regulation of *osm-9* in PD ADL neurons.

*Experiment to link endosiRNA pathway to PD negative regulation of osm-9 would be to do the smFISH in control vs. PD in mut-16 background (at least one of the endosiRNA mutants).*

To further link siRNA pathways to the regulation of *osm-9* in PD ADL neurons, we repeated the smFISH experiment to examine *osm-9* mRNA levels in a *mut-16* strain. To perform this experiment, we genetically crossed the *sre-1*p::*gfp* transgene from wild-type ([Figure 1B](#fig1){ref-type="fig"}) into the *mut-16(mg461)* strain. Our results show that *osm-9* mRNA levels in PD ADL neurons of *mut-16* are significantly increased compared to wild-type ([Figure 4B](#fig4){ref-type="fig"}). These results nicely correlate with our *osm-9*p::*gfp* transgene results ([Figure 4A](#fig4){ref-type="fig"}), and indicate that RNAi pathways are contributing to the down-regulation of *osm-9* (either directly or indirectly, see response \#1) due to developmental history.

*ChIP experiments need negative controls: IP from the null background to examine non-specific IP; IP of an unaffected gene (act-2 was not vetted anywhere in the paper).*

We appreciate the reviewers' suggestion to include additional controls for our ChIP experiments. To address their concerns, our resubmission includes ChIP-qPCR data for the *daf-3* null mutant background for DAF-3 IPs in wild-type ([Figure 3B](#fig3){ref-type="fig"}) and no transgene controls for the ADL-specific ChIP experiments ([Figures 5C](#fig5){ref-type="fig"}, [6B](#fig6){ref-type="fig"} and Figure 6---figure supplement 1). For each experiment, we normalized the ChIP-qPCR data to a negative control (not a known target) and adjusted the data to the null mutant/no transgene controls to better visualize enrichment. We indicate in the figures which IPs show significant enrichment above the null mutant/no transgene controls. We also included positive and negative controls for enrichment for each experiment. For DAF-3 IPs, we examined enrichment at the *daf-8* and *daf-14* as positive and negative controls, respectively ([Figures 3B](#fig3){ref-type="fig"} and [6B](#fig6){ref-type="fig"}). We normalized this data to the negative control, *act-2*. These genes have been previously vetted as either targets or non-targets of DAF-3 (Park, Estevez, et al. 2010). For ZFP-1 IPs, we included *egl-30* and *act-3* genes as negative and positive controls, respectively ([Figure 5C](#fig5){ref-type="fig"} and Figure 6---figure supplement 1). Although ZFP-1 was shown to bind to *egl-30* in whole worms (Cecere et al. 2013), to our knowledge, *egl-30* does not show expression in ADL neurons (wormbase.org). *act-3* is a known ZFP-1 target and is expressed in ADL, so we examined this gene as a positive control (Cecere et al. 2013). The ZFP-1 data was normalized to enrichment at *gst-4* (not a known target) (Cecere et al. 2013).

*Important but omitted: Better description of the osm-9 endosiRNA profiles from control and PD... where do they map in the osm-9 gene?*

To address this concern, we reanalyzed small RNA sequencing data from CON, PD, L3, and dauer whole worms that were previously published (Hall et al. 2013). Unfortunately, we do not yet have small RNA sequencing data from ADL neurons specifically. In addition, the siRNAs mapping antisense to the *osm-9* gene were below the threshold cutoff for enrichment in our previous study; thus, we cannot make solid conclusions about the different numbers of siRNAs in CON versus PD ADL neurons that might be contributing to the differential regulation of osm-9. Despite these limitations, the numbers and mapping locations of the siRNAs homologous to the osm-9 locus in the different developmental stages are indicated in a new [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}. The results indicate that a majority of the siRNAs map to the 3' exons of the *osm-9* gene, as expected for secondary siRNAs generated through the action of an RdRP. This analysis is consistent with our hypothesis that siRNAs generated in the endogenous ERGO-1/NRDE pathways are targeting *osm-9* for transcriptional gene silencing in PD ADL neurons.

*Other questions include:*

*Avoidance of the pheromone ascr\#3 is tested, with the expected results. Can the authors provide control data to show that chemotaxis to unrelated molecules is normal? How specific is this effect-only to ascr\#3 or other pheromones and nonpheromonal odorants?*

This is an excellent question from the reviewers that we believe we have addressed in our first submission. We have shown that attraction to the odorant diacetyl, which is an OSM-9 dependent and AWA mediated behavior, is unaffected by developmental history ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Avoidance of 1 M glycerol, which is an OSM-9 dependent and ASH mediated behavior, is also unaffected in PD adults ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). We have not tested additional pheromone components, since CON adults to do not exhibit an avoidance response to the other major pheromones, such as C3 and C6 (Jang, et al. (2012) Neuron 75: 585-592). We believe that these experiments show that the reduced avoidance to ascr\#3 is specific to the downregulation of *osm-9* in PD ADL neurons.

*Related to this, how pervasive is the effect of the postdauer experience on worm biology? The authors are using osm-9::gfp, allowing them to focus on a few neurons. But are other parts of the chemosensory circuit also affected by the developmental events? Some evidence for specificity would greatly enhance the conclusions.*

We believe that developmental history has profound effects on worm biology that we are just beginning to understand. We have shown previously that brood size and mean life span are significantly altered in PD adults compared to controls (Hall et al. 2010). In addition, we have found significant changes in mRNA levels of numerous genes expressed in neurons between CON and PD, and likely affect multiple behaviors which we hope to address in future work. However, to answer the reviewers' question, ADL and ASH neurons are both electrically coupled to the RMG interneuron. We only observe significant changes in ADL mediated behavior between CON and PD, while ASH mediated behavior remains unaffected (see response \#6). This result would suggest that the remainder of the circuit remains functional, and only ADL function is affected in this study.

*In the last line of the subsection "The TGF-β pathway negatively regulates osm-9 in postdauer animals" [Figure 3D](#fig3){ref-type="fig"} should be 3C.*

Thank you for pointing out this mistake. The correction has been made.

*[Figure 5B](#fig5){ref-type="fig"} authors should consider using an ampersand, as in [Figure 4B](#fig4){ref-type="fig"},to indicate that the zfp-1(ok554)::Ex(ADLp::zfp-1::gfp\] value differs from that of zfp-1(ok554).*

Due to the variability in the ascr\#3 avoidance response in the *zfp-1(ok554)* mutant, the rescue strain expressing ADL-specific ZFP-1 is not significantly different in its behavior. In the manuscript, we describe the ascr\#3 avoidance of the rescue strain as "partially restored".

In the first paragraph of the Discussion the authors may wish to reconsider their use of the term \"transcriptional licensing\".

The text has been changed.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

As you can see, reviewer 2 is still somewhat concerned by the responses provided in the last round of revision. Reviewer 3 has a specific request. Please address reviewer 3\'s request. Please also add the ADL-specific IPs results since you probably have had time to finish that. Once you have these results, we will consider the revised manuscript and provide a swift decision.

Reviewer \#2:

Sims et al. provide a revision that attempts to delve further into the mechanism by osm-9 gene regulation is modulated after early life stress. Responses to the concerns that I raised in the initial review are acceptable. I continue to find the observations that developmental history reduces osm-9 expression, and concomitant reduced sensitivity to pheromone, very interesting. Unfortunately, many of the experiments requested by one of the reviewers produced equivocal or incomplete results. In some cases, necessary controls were unavailable due to technical problems and time constraints for resubmission to eLife. Here is a case where the paper was actually weakened, rather than strengthened, through peer review. My sense is that there are a lot of interesting observations here, but there is a lack of conclusive data to support the mechanistic conclusions shown in [Figure 6](#fig6){ref-type="fig"}. The options would be to give the authors additional time to complete the missing experiments mentioned in the response to reviewers. Alternatively, the authors could back off from the strong conclusions, remove the incomplete data, and resubmit a paper more narrowly focused on the observations that seem robust, but removing the speculation not supported by the data.

Reviewer \#3:

The comments I made in my earlier review have been satisfactorily addressed, except for one point that is not clear:

\"The rescue strain expressing ADL-specific ZFP-1 is not significantly different in its behavior. In the manuscript, we describe the ascr\#3 avoidance of the rescue strain as \"partially restored\".

If the rescue strain is not significantly different from the mutant, then it\'s not clear that it has been partially restored.

As for the comments made by the other reviewers, it seems that the manuscript has been improved. If it would be possible to improve the manuscript much more with a modest extension of the time line, then this would be OK with me.

Specific changes to the newly revised manuscript are described below.

1\) One of the previous requests from the reviewers was to address the interaction of the TGF-β, chromatin remodeling, and RNAi pathways in the regulation of *osm-9* in postdauer ADL neurons. We previously attempted to answer this question by immunoprecipitating GFP-tagged DAF-3 and ZFP-1 from ADL neurons with little success due to technical and biological reasons. We have since performed DAF-3 immunoprecipitations in *mut-16* and *zfp-1* mutant strains using an α-DAF-3 antibody, and found that DAF-3 binding at the *osm-9* locus in postdauer animals is dependent upon functional ZFP-1 and RNAi pathways ([Figure 5D](#fig5){ref-type="fig"}). To our knowledge, this would be the first report of an interaction between DAF-3 with ZFP-1 and RNAi pathways. Although this experiment does not address the interactions of these pathways in ADL specifically, our new results suggest that these pathways may be acting cooperatively at the *osm-9* locus to facilitate its down-regulation in postdauer animals. As reviewer \#2 suggested, we have removed the negative results from the previous revision and simplified our model of *osm-9* regulation, emphasizing that we cannot yet say whether *osm-9* is a direct target of RNAi pathways ([Figure 6](#fig6){ref-type="fig"}).

2\) As Reviewer \#1 suggested, we have added the tRNA and non-coding RNA loci present in the *osm-9* intron to our siRNA map in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}. Only 7 of the 143 siRNAs with homology to *osm-9* overlap with these loci. We have also included the siRNA nucleotide sequences mapping to the *osm-9* locus in [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}---Source data 1.

3\) To address the concerns of Reviewer \#3, we have performed an additional two trials to test the ascr\#3 avoidance behavior of ADL-specific ZFP-1 rescue lines compared to *zfp-1* mutants. These trials were consistent with our previous data, and have improved the statistical power so that the ZFP-1 rescue lines now exhibit behavior that is significantly different from the *zfp-1* mutant line ([Figure 5B](#fig5){ref-type="fig"}). Since the ascr\#3 avoidance of the ZFP-1 rescue lines is also significantly different from wild-type, we have described this result as "expression of ZFP-1 in ADL partially rescued ascr\#3 avoidance behavioral phenotype compared to the *zfp-1* mutant".

[^1]: These authors contributed equally to this work.
